CURRICULUM VITAE AND BIBLIOGRAPHY › uploads › 4 › 1 › 5 › 1 › 41… · Web viewABO incompatible liver transplantation with no immunological graft losses utilizing total

CURRICULUM VITAE AND BIBLIOGRAPHY

PART I: General Information

Date Prepared: May 23, 2018

Name: Douglas W. Hanto, M.D., Ph.D.

Current Title: Deputy Chief of SurgeryVA St. Louis Health Care System

Lewis Thomas Professor of Surgery EmeritusHarvard Medical School

Office Address: ATTN: 112/JCSt. Louis Veteran’s Administration Health Care System915 North Grand AvenueSt. Louis, MO 63106

Home Address: 6806 Waterman Avenue St. Louis, MO 63130-4661

Email: [email protected] [email protected]

Office Phone: 314-289-7917

Place of Birth: Great Falls, Montana, U.S.A.

Education:

8/69-5/73 B.A. Magna cum laude St. Olaf College; Northfield, MN7/73-6/77 M.D. First in Class University of Arizona College of Medicine; Tucson, AZ7/80-7/87 Ph.D. Surgery University of Minnesota; Minneapolis, MN 7/03 M.A. (Hon) Harvard University; Cambridge, MA

Postdoctoral Training:

6/77-6/78 Intern, General Surgery University of Minnesota Health Sciences Center, Minneapolis, MN

7/78-6/84 Resident, General Surgery University of Minnesota Health Sciences Center, Minneapolis, MN

7/80-2/83 Research Fellow, Transplant Immunology University of Minnesota Health Sciences Center, Minneapolis, MN

6/84-8/85 Transplant FellowUniversity of Minnesota Health Sciences Center; Minneapolis, MN

5/03 Leadership Development for Physicians in Academic Centers,Harvard School of Public Health, Boston, MA

Douglas W. Hanto, M.D., Ph.D.

Licensure and Certification:

Licensure:1978-1991 Minnesota Medical License1985-1992 Missouri Medical License1987-1993 Illinois Medical License1988-1991 Arkansas Medical License1991-2006 Ohio Medical License2001- Massachusetts Medical License2013- Missouri Medical License2014- Tennessee Medical License

Certification:1978 National Board of Medical Examiners1986 The American Board of Surgery1995 The American Board of Surgery: Recertification2004 The American Board of Surgery: Recertification2016 The American Board of Surgery: Recertification (valid until 12/31/2026)2008 Basic Life Support and Advanced Cardiac Life Support Certification2008 Fundamentals of Laparoscopic Surgery Certification2010 Basic Life Support and Advanced Cardiac Life Support Certification2012 Basic Life Support and Advanced Cardiac Life Support Certification2016 Basic Life Support and Advanced Cardiac Life Support Certification

Academic Appointments:

1985-1989 Assistant Professor of SurgeryWashington University School of Medicine, St. Louis, MO

1989-1991 Associate Professor of SurgeryWashington University School of Medicine, St. Louis, MO

1991-1997 Associate Professor of SurgeryUniversity of Cincinnati College of Medicine, Cincinnati, OH

1997-2001 Professor of SurgeryUniversity of Cincinnati College of Medicine, Cincinnati, OH

2001-2003 Visiting Professor of SurgeryHarvard Medical School, Boston, MA

2003 Professor of SurgeryHarvard Medical School, Boston, MA

2003-2012 Lewis Thomas Professor of Surgery Harvard Medical School, Boston, MA

2012-present Lewis Thomas Professor of Surgery, EmeritusHarvard Medical School, Boston, MA

2012-2014 Professor of Surgery with TenureWashington University School of Medicine, St. Louis, MO

2014-2017 Professor of Surgery with TenureVanderbilt University School of Medicine, Nashville, TN

2015-present Affiliated Faculty, Center for Biomedical Ethics and SocietyVanderbilt University School of Medicine, Nashville, TN

2017-present Adjunct Professor of SurgeryVanderbilt University School of Medicine, Nashville, TN

2


Hospital or Affiliated Institution Appointments:

07/85-06/91 Attending, Barnes Hospital, St. Louis, MO07/85-06/91 Active Staff, St. Louis Children’s Hospital, St. Louis, MO07/85-06/91 Attending, The Jewish Hospital of St. Louis, St. Louis, MO07/85-06/91 Attending, St. Louis Regional Medical Center, St. Louis, MO07/85-06/91 Consult & Attending, St. Louis Veterans Administration Hospital, St. Louis, MO07/91-11/01 Attending Regular, The University of Cincinnati Hospital, Cincinnati, OH07/91-06/97 Consult, Cincinnati Veterans Administration Hospital, Cincinnati, OH07/92-11/01 Associate, Children’s Hospital Medical Center, Cincinnati, OH07/94-11/01 Courtesy, The Christ Hospital, Cincinnati, OH07/94-11/01 Courtesy, Bethesda Hospital, Cincinnati, OH07/95-11/01 Courtesy, The Jewish Hospital of Cincinnati, Cincinnati, OH07/98-11/01 Affiliate, Deaconess Hospital, Cincinnati, OH07/98-11/01 Consulting, Drake Center, Inc., Cincinnati, OH07/00-11/01 Courtesy, Good Samaritan Hospital, Cincinnati, OH12/01-11/12 Active, Beth Israel Deaconess Medical Center, Boston, MA07/02- 06/06 Courtesy, Children’s Hospital, Boston, MA12/12-09/14 Attending, St. Louis Veterans Administration Hospital, St. Louis, MO10/14-05/17 Attending, Vanderbilt University Medical Center, Nashville, TN10/14-05/17 Attending, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, TN01/17-present Attending, VA St. Louis Health Care System, St. Louis, MO

Other Professional Positions and Major Visiting Appointments:

02/07/2001 Visiting Professor. Institute for Cellular Therapeutics, University of Louisville Health Sciences Center, Louisville, KY. Suzanne T. Ildstad, M.D., Director.

04/03/2001 Visiting Professor. Department of Surgery, Case Western Reserve University, Cleveland, OH. James A. Schulak, M.D., Chairperson.

03/02/2005 Visiting Professor. Department of Surgery, University of Arizona, Tucson, AZ. Marlys Witte, M.D., Professor of Surgery.

06/26/2006 Visiting Professor. Department of Surgery, Mayo Clinic, Rochester, MN. Charles B. Rosen, M.D., Associate Professor of Surgery.

06/09/2009 Visiting Professor. Department of Surgery, Medical University of South Carolina, Charleston, SC. Prabhakar K. Baliga, M.D., Professor of Surgery.

06/02/2011 The Neil Lempert, M.D. Visiting Professor. Albany Medical College, Albany, NY. David J. Conti, M.D., Professor of Surgery.

05/03/2012 Visiting Professor, Department of Surgery, Tulane University, New Orleans, LA. Douglas P. Slakey, Professor and Chair.

Hospital and Health Care Service Organization Responsibilities:

1986-1989 Member, Scientific Advisory Board, National Kidney Foundation of Eastern Missouri and Metro East, Inc., St. Louis, MO

1987-1991 Member, Board of Directors, Mid-America Transplant Association (after 1990 renamed Mid-America Transplant Services*), St. Louis, MO

1988-1989 Member, Technical Review Committee, Missouri Kidney Program, Jefferson City, MO

1996-2001 Member, Medical Advisory Board, LifeCenter*, Cincinnati, OH1999-2001 Member, Board of Trustees, LifeCenter, Cincinnati, OH

3


2000-2001 President, Board of Trustees, LifeCenter, Cincinnati, OH2001-2010 Member, Board of Trustees, New England Organ Bank*, Boston, MA2001-2010 Member, New England Consortium for Liver Transplantation,

New England Organ Bank, Boston, MA2003-2010 Member, New England Consortium for Intestinal Transplantation,

New England Organ Bank, Boston, MA2003-2004 Member, Ad Hoc Transplantation Group,

Department of Public Health, Boston, MA2004-2006 Member, New England Consortium for Pancreas Transplantation,

New England Organ Bank, Boston, MA2004-2012 Representative for Beth Israel Deaconess Medical Center to the Organ Procurement and

Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS), Richmond, VA

2004-2009 Inpatient Medical Director, Transplant Unit, Beth Israel Deaconess Medical Center; Boston, MA

2011 Member, Scientific Advisory Board, Translational Medicine Group, Alexion Pharmaceuticals, Inc., Cambridge, MA

2012 Beth Israel Deaconess Medical Center Representative to the Clinical Policy Board of the New England Organ Bank, Boston, MA

2014-2017 Member, Tennessee Donor Services* Medical Advisory Committee, Nashville, TN2015-2017 Representative for Vanderbilt University Medical Center to the Organ Procurement and

Transplantation Network (OPTN)/United Network for Organ Sharing (UNOS), Richmond, VA

*Regional organ procurement organization (OPO)

Major Administrative Responsibilities:

1988-1991 Director, Section of Transplantation, Washington University School of Medicine, Department of Surgery; St. Louis, MO

1991-2001 Director, Liver Transplant Program, University of Cincinnati College of Medicine, Department of Surgery; Cincinnati, OH

1999-2001 Medical Director, LifeCenter; Cincinnati, OH2001-2012 Chief, Division of Transplantation, Beth Israel Deaconess Medical Center; Boston, MA2003-2008 Co-Director, The Transplant Center, Beth Israel Deaconess Medical Center; Boston, MA2008-2012 Clinical Director, The Transplant Institute, Beth Israel Deaconess Medical Center;

Boston, MA2008-2012 Medical Director, Advanced Vascular Care Center; Boston, MA2008-2010 Acting Academic Chair, Department of Surgery, Beth Israel Deaconess Medical Center;

Representative to Surgical Executive Committee, Harvard Medical School, Boston, MA

2011-2012 Associate Chairman of Surgery, Associate Surgeon-in-Chief, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA

2011- 2012 Vice-Chair for Faculty Development and Academic Affairs, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA

2012-2014 Associate Dean for Continuing Medical EducationWashington University School of Medicine, St. Louis, MO

2012-2014 Program Director, General SurgerySt. Louis VA Medical Center, St. Louis, MO

2014-2015 Associate Director, Vanderbilt Transplant CenterVanderbilt University Medical Center, Nashville, TN

2014-2017 Chief of Pediatric Liver Transplant, Monroe Carell Jr. Children’s Hospital at Vanderbilt

4


Vanderbilt University Medical Center, Nashville, TN2015-2016 Director, Vanderbilt Transplant Center

Vanderbilt University Medical Center, Nashville, TN2017-present Deputy Chief of Surgery

St. Louis Veteran’s Administration Health Care System, St. Louis, MO

Major Committee Assignments:

Washington University School of Medicine, St. Louis, MO:1988-1991 Member, Postgraduate Medical Scientist (M.D., Ph.D.) Program Advisory Committee

Barnes Hospital, St. Louis, MO:1985-1991 Member, Barnes Hospital Organ Transplantation Committee1988-1991 Member, Pharmacy and Therapeutics Committee

St. Louis Children’s Hospital, St. Louis, MO:1990-1991 Member, Advisory Committee for the Pediatric Clinical Research Center

University of Cincinnati College of Medicine, Cincinnati, OH:1992-1993 Member, Cancer/Environmental Health Subcommittee

Focus Area Review Task Force1996-1997 Chair, Transplantation Programs Task Force1997-1998 Member, Department of Surgery Clinical Study Evaluation Committee

University of Cincinnati Hospital, Cincinnati, OH:1995-1996 Member, Clinical Practice Improvement Team1995-1996 Member, Surgery Clinical Practice Improvement Cost Reduction Team1995-1996 Chair, Liver Transplant Clinical Practice Improvement Team1997-1998 Member, Essential Services Committee2000-2001 Member, Organ Donation Committee

The Health Alliance of Greater Cincinnati, Cincinnati, OH:1996-1999 Chair, Clinical Resource Management Group for Transplantation

Ohio Solid Organ Transplant Consortium (OSOTC), Columbus, OH:1993-2001 Chair, Small Bowel Transplant Selection Committee1996-2001 Member, Members Council1996-2001 Member, Board of Trustees

1997-1998 Chair1999-2000 Treasurer2000-2001 Secretary

1998-2001 Chair, Liver Transplant Selection Committee

Beth Israel Deaconess Medical Center, Boston, MA:2001-2003 Member, Organ Donation Council 2001-2012 Co-Chair, Liver Transplant Selection Committee2001-2012 Co-Chair, Kidney Transplant Selection Committee2002-2003 Member, Volume Development Subcommittee 2002-2010 Member, Network Development Committee2002-2009 Member, Operating Room Work Environment Committee2002-2012 Chair, Transplant Center Executive Committee

5


2002-2012 Member, Operating Room Executive Committee2003-2005 Chair, Subcommittee on OR PACS Imaging2003-2005 Member, Perioperative Operations Committee

2002-2006 Member, Housestaff Education Committee, Department of Surgery2002-2012 Member, Appointments, Reappointments and Promotions (ARP) Committee,

Department of Surgery2003-2004 Member, Surgery Intensive Care Unit Working Committee2003-2004 Member, Operating Room Supply Committee

2003-2004 Chair, Wound Closure Task Force2003-2012 Member, Board of Directors, Department of Surgery Foundation, Inc.

2009 Chair, Department of Surgery Foundation Scholarship Committee2004-2012 Member, Transplant Research Center Executive Committee2004-2012 Chair, Transplant Center Operations Committee2004-2009 Member-at-Large, Medical Executive Committee2006-2008 Co-Chair, Committee to Search for Director of HLA Laboratory at

Beth Israel Deaconess Medical Center 2006-2009 Member, Board of Directors, Harvard Medical Faculty Physicians2007-2009 Member, Surgical Patient Care Committee2007-2009 Member, BIDMC Web Redesign Task Force2008-2012 Member, Committee on Senior Appointments2009-2012 Member, Credentials Committee2011-2012 Member, Research Finance and Philanthropy Committee2012-2012 Member, Strategic Plan Integration Committee2012-2012 Member, Mentor-Education Advisory Committee

Harvard Medical School, Boston, MA:2002-2003 Member, Ad Hoc Committee to Search for Chair, Department of Orthopedic Surgery at Beth

Israel Deaconess Medical Center2002-2003 Member, Ad Hoc Committee to Search for an Assistant/Associate Professor to serve as a

Clinical Surgeon in the Division of Vascular Surgery at Beth Israel Deaconess Medical Center2003-2005 Co-Chair, Ad Hoc Committee to Search for Chief of Surgical Oncology at Beth Israel

Deaconess Medical Center2003-2005 Member, Ad Hoc Committee to Search for Chair, Department of Pathology at Beth Israel

Deaconess Medical Center2004-2005 Chair, Ad Hoc Committee to Search for a Professor of Surgery to serve as Head of the

Division of Trauma and Critical Care at Beth Israel Deaconess Medical Center2004-2007 Member, Promotions, Reappointments, and Appointments Committee2004-2005 Chair, Ad Hoc Committee to Search for a Professor of Surgery to serve as Chief, Division of

Vascular and Endovascular Surgery at Beth Israel Deaconess Medical Center2005-2006 Member, Ad Hoc Committee to Search for a Professor of Surgery to serve as Chief of

Transplant Surgery at Massachusetts General Hospital2005-2006 Member, Ad Hoc Committee to Search for a Professor of Surgery to serve as Chief, Division

of Neurosurgery at Beth Israel Deaconess Medical Center2005-2006 Member, Medical Education Reform In-Depth Experience Committee

2005-2006 Member, Patient-Oriented Research Subcommittee2005-2006 Member, In-Depth Concentrations Design Group

2006-2007 Member, Task Force on Promotion Criteria2006-2007 Member, Ad Hoc Committee to Search for a Professor of Surgery to serve as Clinical Chief of

Nephrology at Beth Israel Deaconess Medical Center-Joslin Clinic2006-2007 Chair, Ad Hoc Committee to Evaluate the Appointment of Joren Madsen, M.D., D.Phil., as

Professor of Surgery, full time, Investigator Criteria, to serve at Massachusetts General Hospital

6


2006-2007 Member, Ad Hoc Committee to Search for a Professor of Neurosurgery to serve as Chair of the Department of Neurosurgery at Brigham and Women’s Hospital

2006-2008 Member, Ad Hoc Committee to Evaluate the Appointment of John J. Reilly, Jr., M.D., as Professor of Medicine, full time, Clinician-Teacher Criteria, to serve at Brigham and Women’s Hospital

2006-2007 Member, Ad Hoc Committee to Evaluate the Appointment of Takashi Maki, M.D., Ph.D. as Professor of Surgery (full-time), Investigator Criteria, to serve at Beth Israel Deaconess Medical Center

2007-2008 Member, Ad Hoc Committee to Search for a Professor of Surgery to serve as Vice Chairman for Clinical Resources in the Department of Surgery at Beth Israel Deaconess Medical Center

2007-2008 Member, Ad Hoc Committee to Search for a Professor of Radiology to serve as Chair of the Department of Radiology at Beth Israel Deaconess Medical Center

2007-2008 Member, Ad Hoc Committee to Search for an Assistant/Associate Professor to serve as a Clinical Surgeon in the Division of Vascular Surgery at Beth Israel Deaconess Medical Center

2007-2008 Member, Ad Hoc Committee to Search for a Professor of Anaesthesia, full time, to serve as Chairperson of the Department of Anesthesia and Critical Care at Beth Israel Deaconess Medical Center

2007-2012 Member, Executive Committee, Harvard Longwood Medical Area Training Grant in Transplantation (T32 AI070085-01A1 from NIAID, PI John Iacomini, Ph.D.)

2008-2009 Member, Ad Hoc Committee to Search for the Head of the Department of Obstetrics, Gynecology and Reproductive Biology at the Beth Israel Deaconess Medical Center and as the Harold H. Rosenfield Professor at Harvard Medical School

2008-2010 Member, Ad Hoc Committee to Search for a Professor of Medicine, full time, to serve as Associate Director for Clinical Programs in the Cancer Center at Beth Israel Deaconess Medical Center

2008-2009 Member, Ad Hoc Committee to Search for a Professor of Surgery, full time, to Serve as Chief of the Department of Neurosurgery at Beth Israel Deaconess Medical Center

2008-2012 Member, Ad Hoc Selection Committee to Review Applications for the Doris Duke Clinical Scientist Development Award (CSDA) and Select Harvard Medical School Nominees

2008-2009 Member, Ad Hoc Search Review Committee to Evaluate the Proposed Appointment of Jeanine Weiner-Kronish, M.D., as Professor of Anaesthesia at Harvard Medical School

2008-2010 Member, Ad Hoc Committee to Search for a Professor of Psychiatry, full time, to serve as Chair of the Department of Psychiatry at Beth Israel Deaconess Medical Center

2008-2010 Member, Ad Hoc Committee to Search for a Professor of Surgery or Medicine, full time, to serve as CEO of the Cardiovascular Institute (CVI) at Beth Israel Deaconess Medical Center

2009-2010 Member, Task Force on Faculty Development and Diversity2009-2010 Member, Streamlining Promotions Task Force 2009-2012 Member, Subcommittee of Professors 2009 Chair, Ad Hoc Committee to Search for a Professor of Surgery, full time, to serve in the

Division of Trauma and Critical Care at Beth Israel Deaconess Medical Center2009-2011 Member, Self-Study Subcommittee on Faculty for Site Visit by the Liaison Committee on

Medical Education (LCME) March 6-9, 2011 2009-2011 Member, Ad Hoc Committee to Search for a Professor of Surgery, full time, to serve as Head

of the Department of Surgery at Massachusetts General Hospital. 2011-2012 Member, Standing Committee on Conflicts of Interest and Commitment2011 Chair, Ad Hoc Committee to Search for a Professor of Surgery, full time, to serve as Chief of

the Division of Health Services Research at Beth Israel Deaconess Medical Center2011-2012 Member, Advisory Committee to the Office of Faculty Affairs2011-2012 Chair, Ad Hoc Committee to Search for an Assistant/Associate Professor to serve as a Surgeon

in the Division of Transplantation at Beth Israel Deaconess Medical Center2011 Member, Ad Hoc Selection Committee to Review Applications for the Mary Kay Innovative/

Translational Cancer Research Award and Select Harvard Medical School Nominees

7


2012 Member, Advisory Council on Organ and Tissue Transplants and Donations, Commonwealth of Massachusetts

2012 Chair and Facilitator, Ad Hoc Committee evaluating Dr. Lawrence C. Tsen for appointment as Professor of Anaesthesia, to serve at Brigham and Women's Hospital

2012 Chair, Committee for the Memorial Minute on the Life of Fritz H. Bach, M.D.2012 Member, Ad Hoc Committee to Search for an Associate Professor or Professor of Surgery to

serve as Chief of the Massachusetts General Hospital Division of Burns Surgery

Washington University School of Medicine, St. Louis, MO:2012-2014 Member, Education Leadership Council2013-2014 Member, Department of Surgery Working Group2013-2014 Chair, CME Strategic Planning Committee

Vanderbilt University School of Medicine, Nashville, TNAdministrative Committees2014-2016 Co-Chair, Transplant Center Business Committee2014-2016 Member, Patient Care Center Committee

Selection Committees2014-2016 Member, Pediatric Heart Transplant Selection Committee2014-2016 Member, Pediatric Kidney/Pancreas Transplant Selection Committee2014-2016 Member, Pediatric Living Donor Transplant Selection Committee2014-2016 Member, Adult Liver Transplant Selection Committee2014-2016 Member, Adult Heart Transplant and Ventricular Assist Device Selection Committee2014-2016 Member, Adult Lung Transplant Selection Committee2014-2016 Member, Adult Kidney/Pancreas Transplant Selection Committee2014-2016 Member, Living Donor Transplant Selection Committee2015-2017 Co-Chair, Pediatric Liver Transplant Selection Committee

Operations Committees2014-2016 Member, Adult Liver Transplant Operations Committee2015-2016 Co-Chair, Transplant Center Operations Committee2015-2017 Co-Chair, Pediatric Liver Transplant Operations Committee

Quality Assessment and Performance Improvement Committees (QAPI)2014-2016 Co-Chair, Transplant Center Quality Council2014-2016 Member, Pediatric Heart Transplant Quality Assessment and Performance Improvement

Committee2014-2016 Member, Pediatric Kidney/Pancreas Transplant Quality Assessment and Performance

Improvement Committee2014-2016 Member, Adult Liver Transplant Quality Assessment and Performance Improvement

Committee2014-2016 Member, Adult Heart Transplant Quality Assessment and Performance Improvement

Committee2014-2016 Member, Adult Lung Transplant Quality Assessment and Performance Improvement

Committee2014-2016 Member, Adult Kidney/Pancreas Transplant Quality Assessment and Performance

Improvement Committee2014-2016 Member, Adult Living Donor Transplant Quality Assessment and Performance Improvement

Committee2015-2017 Co-Chair, Pediatric Liver Transplant Quality Assessment and Performance Improvement

Committee

8


2015-2016 Member, 7T3 Performance Improvement Operational Committee

Institutional2015-2016 Member, Center Directors Committee 2015-2016 Member, Executive Medical Directors Committee2016 Member, Vanderbilt University Medical Center Ethics Committee2016 Member, Committee to Search for a Chief Operating Officer to serve at Vanderbilt University

Hospital

VA St. Louis Health Care System, St. Louis, MO2017- present Member, Executive Board, VA St. Louis Health Care System2017- present Member, Focused Surgical Work Group2017-present Member, Operating Room Executive Committee2017-present Member, Fiscal Committee2018-present Member, Ethics Consultation Service

National:*1988-1998 Member, Board of Medical Advisors, World Children’s Transplant Fund; Los Angeles, CA1989-2008 United Network for Organ Sharing (UNOS), Richmond, VA

Liver and Intestinal Organ Transplantation Committee:1989-1991 Region XIII Representative1999-2001 Region X Representative2000-2003 Vice-Chair2000-2003 Member, Liver Allocation and Distribution Subcommittee

2000-2003 Member, Liver Disease Severity Subcommittee2001-2003 At-Large MemberRegion 10 Review Board1999-2001 ChairRegion 1 Review Board2001-2003 MemberEthics Committee2004-2008 Member2004-2007 ASTS Representative, UNOS Ad Hoc Solicitation CommitteeRegion 11 Review Board2015-2016 Member

1989-1995 Member, Surgical Advisory Board, Smith, Kline, Beecham; Philadelphia, PA1989-1990 Member, Ad Hoc Review Committee, Liver Transplantation Center,

National Institutes of Diabetes, Digestive, and Kidney Diseases; Bethesda, MD1994-1995 Special Reviewer, Surgery, Anesthesiology, and Trauma Study Section,

National Institutes of Health; Bethesda, MD1995-1997 Member, Ortho Biotech Institute Advisory Board, Ortho Biotech; Raritan, NJ1998-2000 Member, Board of Directors, CenterSpan; Ann Arbor, MI2002 Special Reviewer, Surgery, Anesthesiology, and Trauma Study Section,

National Institutes of Health; Bethesda, MD2005-2009 Member, Transplantation Advisory Council, American Board of Surgery2006-2007 Member, Organizing Committee for Research Workshop on Future Challenges in Pediatric

Liver Transplantation; Liver Diseases Research Branch, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health; Bethesda, MD

2007-2008 Member, External Advisory Board for T32 Training Grant in Transplant Immunology at the University of Wisconsin (PI, Stuart J. Knechtle, M.D.)

9


2008 Chair, Ad Hoc Review Committee, Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL), Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Bethesda, MD

2009-2015 Director, American Board of Surgery2009-2015 Chair, Transplantation Advisory Council2009-2015 Member, Chairs Committee2009-2015 Member, Qualifying Examination Committee2009-2015 Member, Credentials Committee2013-2015 Chair, Credentials Committee2009-2011 Member, Diplomates Committee

2015-present Senior Director, American Board of Surgery2009 Chair, Ad Hoc Review Committee, Adult-to-Adult Living Donor Liver Transplantation Cohort

Study (A2ALL) (UO1), Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Bethesda, MD

2011-2012 Member, Data Safety Monitoring Board (DSMB), Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL), NIH/NIDDK, Bethesda, MD

2011 Member, Planning Committee, Animal Models of IRI, DGF, SGF Session, FDA Workshop: "Ischemia reperfusion injury and down stream effects of delayed graft function, other short term and long term outcomes in kidney transplantation." Silver Spring, MD; September 8-9, 2011.

*See also Professional Societies

International*2009 Team Chair, “Classification of PTLD and the Impact of EBV”. Seville PTLD Consensus

Meeting (Genzyme); Seville, Spain, November 13-14. 2009-2010 Member, Organizing Committee, Consensus Conference on HCC and Liver Transplantation;

Zurich, Switzerland (November, 2010)2011-2012 Chair, "Societal & Ethics" Program Committee, XXIV International Congress of The

Transplantation Society (International); Berlin, Germany, July 15-19, 2012. 2012-2013 Member, Scientific Committee, 3rd ELPAT Congress of The Transplantation Society

(International), "Organ Transplantation: Ethical, Legal and Psychosocial Aspects, Outreach from the European Platform." Rotterdam, The Netherlands, April 20-24, 2013.

*See also Professional Societies

Professional Societies:

1983-2007 American Association for the Advancement of Science1985-2001 Association for Academic Surgery

1987-1989 Member, Program Committee1986-2017 American Association for the Study of Liver Diseases

2001-2003 Chair, Clinical Transplantation and All Other Transplantation Review Group for Annual Meeting

2001-2004 Member, Experimental Transplantation; Preservation, Ischemia/Reperfusion; Cell Transplantation; Hepatobiliary Abstract Review Committee for Annual Meeting

2004-2006 Member, Clinical Transplantation and All Other Transplantation Review Group for Annual Meeting

2005-2007 Chair, Surgery and Liver Transplantation Committee2005-2007 Representative to United Network for Organ Sharing2005-2007 Member, Scientific Program Committee

10


2007-2009 Councilor-at-Large, Governing Board2008-2010 Member, Awards Committee2009-2010 Member, Liver Transplantation Special Interest Group

Steering Committee 2009-2011 Member, Clinical Liver Transplantation and Liver Surgery -

Immunosuppression, Outcomes, and Complications Abstract Review Committee2010-2011 Chair

2014- Fellow, American Association for the Study of Liver Diseases (FASLD)2016- American Society for Bioethics and Humanities1986- American Society of Transplant Surgeons

1991-1994 Member, Medical Data Review Committee 1994-1996 Member, Education Committee1994-1998 Member, Informatics and Data Management Committee1997-1998 Member, Nominations Committee1997-2000 Member, Government and Scientific Liaison Committee to United Network for Organ Sharing 1995-1998 Councilor-at-Large, Board of Directors (Council)1998-2001 Chair, By-Laws Committee1998-1999 Chair, Ad hoc Committee on Communications1999-2000 Member, Ad hoc Committee on Public Policy2001-2004 Member, Advisory Committee on Issues2002 Member, Planning Council, 2003 Winter Symposium 2002-2005 Chair, Ethics Committee2002-2008 Member, Ad hoc Committee on Professional Reimbursement2004-2007 ASTS Representative, UNOS Ethics Committee2005-2007 Member, Ad hoc Committee on Transplant Codes2005-2007 ASTS Representative, UNOS Ad Hoc Solicitation Committee2006-2008 Member, Standards on Organ Transplantation Committee2008-2010 Member (Representative from American Board of Surgery),

MOC (Maintenance of Certification) Committee2008-2015 Chair, Government and Scientific Liaison Committee2009-2015 Representative of ASTS, to the American Board of Surgery2010-2013 Member, Philanthropy Committee2011, 2014 Reviewer for Awards Committee 2014-2015 Member, Certifying Task Force

1986- The Transplantation Society (International)2006-2010 Member, Ethics Committee2009-2010 Member, Organizing Committee, XXIII International Congress of the

Transplantation Society, Vancouver, BC (August, 2010)2010-2012 Chair, Ethics Committee2011-2012 Chair, "Societal & Ethics" Program Committee for the XXIV

International Congress, Berlin, Germany (July, 2012) 2012-2013 Member, Scientific Committee, 3rd ELPAT Congress, Rotterdam, The

Netherlands (April, 2013)1987-2000 American Association of Immunologists1988- Fellow, American College of Surgeons (FACS)

1996-2001 Member, District #4 Committee on Applicants1988-2008 American Liver Foundation

2003 Member, Bid for Life Committee2004-2008 Member, Medical Advisory Committee, New England Chapter

1988-2003 Collegium Internationale Chirurgiae Digestivae (ISDS)

11


1988-2001 Society of University Surgeons1989-1995 Representative, Council of Academic Societies

1989-2007 Central Surgical Association 1989-2006 European Society for Organ Transplantation1990-2017 American Society of Transplantation1990-2017 International Liver Transplantation Society1991-2001 Cincinnati Academy of Medicine1991-2001 Cincinnati Graduate Surgical Society1991-2001 Ohio State Medical Association1992-2006 Cell Transplant Society1993-2003 Surgical Infection Society1994-2017 American (now Americas) Hepato-Pancreato-Biliary Association

2004-2008 Member, Program Committee1994-2015 International Hepato-Pancreato-Biliary Association (American Chapter)1995-2001 American College of Surgeons, Ohio Chapter1996- American Surgical Association1996-2004 Society for Surgery of the Alimentary Tract

2003-2004 Member, Nominating Committee2001-2008 Lillehei Surgical Society2002-2017 Massachusetts Medical Society2002-2012 American College of Surgeons, Massachusetts Chapter2003- The Halsted Society2003- Boston Surgical Society2006-2017 New England Surgical Society2007- Owen H. Wangensteen Surgical Society2014-2017 International Pediatric Transplantation Society

Community Service Related to Professional Work:

1991, 1993, Volunteer General Surgeon, Medical Ministry International; 1995, 1996, Santo Domingo, Dominican Republic 2001 2003-2008 Red Sox Mentor, Beth Israel Deaconess Medical Center; Boston, MA

Other Educational Activities Related to Professional Work:

2003 Leadership Development for Physicians in Academic Health Centers, Harvard School of Public Health, November 9-21, 2003, Boston, MA

2009 Executive Development Seminar for Associate Deans and Department Chairs, Association of American Medical Colleges, October 9-13, 2009, Ft. Lauderdale, FL

2013 Facilitation Skills for LeadersCenter for Clinical Excellence, BJC Healthcare, August 8-9, 2013, St. Louis, MO

2013 Accelerating Change and Transitions (ACT)Center for Clinical Excellence, BJC Healthcare, October 23-25, 2013, St. Louis, MO

2013 Basics of Lean Leadership in a Healthcare EnvironmentCenter for Clinical Excellence, BJC Healthcare, November 5, 2013, St. Louis, MO

2013 Project Initiate and PlanCenter for Clinical Excellence, BJC Healthcare, November 7-8, 2013, St. Louis, MO

2013 Foundations of Project ManagementCenter for Clinical Excellence, BJC Healthcare, December 11-13, 2013, St. Louis, MO

2014 KT Problem Solving and Decision MakingCenter for Clinical Excellence, BJC Healthcare, March 12-14, 2014, St. Louis, MO

12


Editorial Boards:

1987-2001 Member, Editorial Board, Transplantation2001-2005 Member, Editorial Board, Liver Transplantation

2008 Member, Editor Search Committee2005-2006 Current Opinion in Organ Transplantation

Section Editor, Liver Transplantation2007 Member, Evaluation Board, Faculty of 1000 Medicine,

Liver Failure and Liver Disease Section, Gastroenterology & Hepatology FacultyOnline service for researchers and clinicians

2007-2015 Associate Editor, American Journal of Transplantation2011-2015 Section Co-Editor, “Images in Transplantation”

2008-2012 Member, Editorial Board, Transplantation2009-2013 Member, Editorial Board, World Journal of Gastrointestinal Surgery2011- Member, Editorial Board, Transplantation Research2014- Expert Reviewer, Center for Evidence in Transplantation2016-2017 Current Opinion in Organ Transplantation

Section Editor, Controversies in Organ Transplantation

Ad hoc reviewer for: American Journal of GastroenterologyAmerican Journal of Kidney DiseasesAmerican Journal of TransplantationAnnals of SurgeryAnnals of Thoracic SurgeryClinical TransplantationHepatologyJournal of the American College of SurgeonsJournal of the American Society of NephrologyJournal of Gastroenterology and HepatologyJournal of HepatologyNew England Journal of MedicineSurgeryTransplant InternationalTransplant Library

Awards and Honors:

1973 Magna cum laude, St. Olaf College1973 Phi Beta Kappa, St. Olaf College1973 Blue Key Honor Society, St. Olaf College1977 Alpha Omega Alpha, University of Arizona College of Medicine1977 Arizona Foundation Outstanding Senior Award (First in Class),

University of Arizona College of Medicine1986 Smith, Kline, and French Fellowship of the American College of Surgeons2003 The Halsted Society2003-2014, 2017Best Doctors in America 2005 First “Charles Witte Legacy Lecture,” University of Arizona College of Medicine2005 Boston Red Sox Medical All Star2005 University of Minnesota 2005 Surgical Alumnus of the Year2006 Boston’s Best Doctors, Boston Magazine

13


2010 International Liver Transplant Society Mentoring Award for Rising Star Award Given to Kaori Kuratmitsu, M.D., Ph.D.

2011 Douglas Hanto Research Scholarship, given by Mr. Ted Boylan to provide for five years of funding to allow four second-year residents each year to attend a week-long intensive course in comparative physiology at Mount Desert Island Biological Laboratory (MDIBL), Mount Desert, Maine.

2012 Nominated for Schwartz Center Compassionate Caregiver Award®; Boston, MA

2014, 2017 Best Doctors in St. Louis, St. Louis Magazine

PART II: Research, Teaching, and Clinical Contributions

A. Narrative Report of Research, Teaching, and Clinical Contributions:

Basic research: My recent laboratory research has focused on the ability of carbon monoxide (CO) at low concentrations to be protective in rodent and large animal models of ischemia-reperfusion injury (IRI) and delayed graft function (DGF), allograft rejection and survival, and in hepatic regeneration. We have shown in a novel kidney allograft model of DGF in swine that treatment of the recipient with intra-operative inhaled CO using a novel CO gas delivery system is effective in restoring kidney function more rapidly than in non-CO treated animals and accelerating the recovery of renal function post-transplant. CO reduced acute tubular necrosis, apoptosis, tissue factor expression and P-selectin expression and enhanced proliferative repair as measured by phosphorylation of retinol binding protein and histone H3. Gene microarray analyses with confirmatory PCR of biopsy specimens showed that CO blocked proinflammatory gene expression of MCP-1 and heat shock proteins. We are interested in determining the optimal treatment regimen (dose, duration, timing), and studying whether CO treatment will allow longer cold storage time, what role O2 plays in the efficacy of CO, and importantly, whether treatment of the donor and the allograft will further limit DGF. This work was the basis for the initiation of a human clinical trial of CO in organ donation and transplantation to prevent DGF. We have also demonstrated in a mouse model of partial hepatectomy that CO enhances rapid and early hepatocyte proliferation by stellate cells that is mediated by hepatocyte growth factor that activates the c-Met receptor on hepatocytes to accelerate hepatocyte proliferation through an Aktcyclin-dependent pathway. CO also preserves function after partial hepatectomy. We have also shown in a fibrotic model of partial hepatectomy that there is progenitor (oval) cell expansion, an increase in profibrogenic gene expression, and de novo collagen deposition that can be blocked using TWEAK (tumor necrosis factor-like weak inducer of apoptosis)-neutralizing antibody that also then leads to augmentation of liver regeneration which has implications for hepatectomy outcomes in patients with liver fibrosis.

Clinical research: A complication of immunosuppression is the development of post-transplant lympho-proliferative diseases (PTLD). My colleagues and I were the first to clearly describe the clinical syndromes associated with these PTLD, their association with the Epstein-Barr virus (EBV), and that they were polyclonal B-cell proliferations that could evolve into monoclonal B-cell proliferations. We were the first to define the morphological features of these polymorphic lymphoproliferations and to propose their classification as polymorphic diffuse B-cell hyperplasia or polymorphic B-cell lymphoma. The two papers published in Cancer Research remain the classic descriptions and have been the basis for many subsequent clinical, immunopathologic, and virologic studies of these diseases. We were also the first to report the clinical use of acyclovir in a patient with EBV infection and showed suppression of oropharyngeal shedding of EBV during acyclovir therapy and regression of a polyclonal B-cell proliferation. By examining immunoglobulin gene rearrangements and cytogenetic abnormalities, we were able to demonstrate in predominantly polyclonal B-cell proliferations, a subpopulation of B-cells that were monoclonal and in some cases oligoclonal. Polyclonal proliferations were shown to evolve into monoclonal B-cell lymphomas and were no longer responsive to anti-viral therapy. The elucidation of

14


the pathogenesis of the EBV-related PTLD has improved the ability to prevent and treat these diseases, leading to improved patient survival. Recent studies have been focusing on the relative risks of various immunosuppressive drugs and combinations of drugs in the development of PTLD. We have also published data defining when it is safe to retransplant patients with a history of PTLD.

I have been actively involved in other clinical trials examining: the safety and efficacy of kidney and liver transplantation in HIV+ patients; ABO incompatible liver transplants; utilizing donors after circulatory determination of death; new immunosuppressive drugs and combinations in kidney and liver transplant patients; clinical pathways in improving the quality and consistency of transplant patient care; the psychosocial aspects of transplantation; and many others.

I have also written and spoken about some of the ethical challenges and controversies in transplantation such as solicitation of donor organs, buying and selling of organs, lung allocation and others. I have served as Chair of the Ethics Committees for the ASTS and TTS. In collaboration with Keren Ladin, MSc, PhD we have examined the complex nature of disparities in transplantation and the important role of social networks in live donor kidney transplantation in African-American patients.

Clinical Practice: I have been actively involved in deceased donor and living-related donor kidney, liver, and pancreas transplantation, deceased donor and donor after cardiac death organ procurement, dialysis access, and nontransplant hepatobiliary surgery. My primary focus is liver transplantation and non-transplant hepatobiliary surgery in adult and pediatric patients.

Teaching: My teaching responsibilities include teaching medical students, surgical interns and residents, and transplant fellows on the clinical wards, in the operating room, in the laboratory, and in the classroom. This involves teaching an organized approach to the pre-operative evaluation and care of patients with surgical diseases, the performance of the surgical procedure itself including surgical technique and decision-making in the operating room, and care of the post-operative patients and their complications.

In my position as Associate Dean for Continuing Medical Education and Professor of Surgery at Washington University School of Medicine I was responsible for the oversight, administration, and provision of learning opportunities for physicians and allied health professionals. The strategic areas of focus were: patient safety and quality improvement; content development and knowledge transfer; technology and content delivery; and outreach and engagement.

Administration/Leadership: With the cooperation of many clinicians and the support of the hospital, I led a turnaround of the BIDMC clinical transplant program to a position of being one of the two largest and most comprehensive programs in New England with an emphasis on innovation, quality, outcomes, and patient service. I aligned support from the hospital administration and the departments of surgery, medicine, pathology, and research to develop an integrated business plan that combines volume, quality, and financial benchmarks for inpatient, outpatient, ancillary services, and research in what I refer to as a “mutual accountability model.” The model was accepted as a monitoring tool by all stakeholders and has been cited as a blueprint for other centers. We improved patient service and satisfaction and the clinical financial model and performance. I worked collaboratively with Dr. Terry Strom and Dr. Larry Turka to build on the strengths of the basic and translational research program that saw growth and expansion in NIH and other funding in the areas of tolerance induction, cytoprotection, liver regeneration, molecular profiling, vascular biology, and immunology. As Vice-Chair for Faculty Development and Academic Affairs, I was responsible for all academic appointments and promotions for the faculty in the Department of Surgery at Harvard Medical School. I met regularly with faculty members to assist them in career planning and advancement. I served on the Subcommittee Professors for HMS and was also on the task force that revised the criteria for promotion at HMS.

15


As the current Director of the Vanderbilt Transplant I am responsible for the administrative and clinical aspects of the adult and pediatric programs in heart, kidney, liver, lung, and pancreas transplantation. I am also responsible for the center’s support of research and educational program development

B. Funding Information:

Past Funding:1982-1985 Principal Investigator for subproject. NIH AM 13083: Program Project Grant.

“Studies of transplantation in mice and man. Clinical IIb. Immune defects in organ transplant recipients with Epstein-Barr Virus (EBV) infections and relationship to post-transplant lymphoproliferative disorders”

1986-1987 Principal Investigator. Biomedical Research Support Grant (BSRG), Washington University School of Medicine 3325-52911A.“Allograft rejection mediated by functionally distinct T cell clones”

1986-1988 Principal Investigator. Smith, Kline, and French Fellowship of the American College of Surgeons 22989269067. “Adoptive transfer of functionally distinct T cell clones in a new T cell depleted mouse model to determine the cellular mediators of rejection”

1986-1989 Principal Investigator. NIH/NIAID RO1 AI24151. “Allograft rejection in a new T cell depleted mouse model”

1987-1988 Principal Investigator. American Cancer Society Institutional Research Grant, Washington University School of Medicine IN-36-28-#3. “T cell control of tumor growth in mice with severe combined immunodeficiency”

1988-1989 Principal Investigator. Ortho Pharmaceutical Corporation.“Evaluation of immune response to OKT3 monoclonal antibody in transplant recipients”

1989-1994 Co-Investigator. NIH/NIAID. “Immunoregulatory role of anti-idiotypic antibodies to HLA”

1992-1994 Co-Principal Investigator. Ortho Biotech. “The effects of pentoxifylline on clinical symptoms and cytokine release associated with OKT3 therapy in liver transplant patients”

1993-1995 Co-Principal Investigator. Pfizer-Roerig. “Randomized, controlled study of Fluconazole vs. Clotrimazole and Nystatin in the prevention of fungal infections in liver transplant recipients”

1994-1995 Site Principal Investigator. Sandoz Pharmaceuticals Corporation; “A prospective, randomized, comparative, multicenter safety and tolerability study of Neoral vs. Sandimmune in primary liver transplant patients”

1996-1998 Principal Investigator. Ortho Biotech.“A comparative study of low dose OKT3-based immunosuppression vs. cyclosporine/mycophenolate-based immunosuppression following liver transplantation”

1997-1999 Site Principal Investigator. Novartis Pharmaceuticals Corporation. “A multicenter, double blind, placebo controlled trial of Simulect in de novo liver transplant recipients”

2000-2001 Co-Investigator. Fujisawa Pharmaceuticals Corporation. “Retrospective analysis of outcomes and resource allocation in liver transplantation”

2000-2006 Co-Investigator. SangStat Medical Corporation.“A pilot study to determine the safety and efficacy of infusion of donor specific cytokine-mobilized peripheral blood bone marrow stem cells (PBSCs) into renal allograft recipients to induce donor specific hyporesponsiveness/unresponsiveness evidenced by reduction in prednisone and other immunosuppressive maintenance drug requirements”

2004-2005 Co-Investigator. Novartis Pharmaceuticals Corporation.“A one-year, multicenter partially blinded, double-dummy, randomized study to evaluate the efficacy and safety of FTY720 combined with reduced-dose or full-dose Neoral and

16


corticosteroids versus mycophenolate mofetil (MMF, CellCept) combined with full-dose Neoral and corticosteroids in de novo adult renal transplant recipients”

2004-2006 Co-Investigator. Roche Laboratories.“Open label, prospective, randomized controlled, multi-center study assessing fixed dose vs. concentration controlled CellCept regimens for patients following a single organ renal transplantation in combination full dose and reduced dose calcineurin inhibitors”

2004-2009 Co-Investigator. NIH/NIAID AI63623 “Clinical trials in organ transplantation”

2005-2008 Co-Investigator. Roche Laboratories.“A prospective, open-label, multi-center randomized trial of the efficacy and safety of long term calcineurin inhibitor free maintenance regimen with mycophenolate mofetil and sirolimus in recipients of an orthotopic liver transplant”

2005-2008 Co-Investigator. Roche Laboratories.“Open label, prospective, randomized controlled, multi-center study assessing fixed dose vs. concentration controlled CellCept regimens for patients following a single organ renal transplantation in combination full dose and reduced dose calcineurin inhibitors”

2005-2008 Co-Investigator. Bristol-Myers Squibb.“Belatacept evaluation of nephroprotection and efficacy as first-line immunosuppresion trial-extended criteria donors”

2006-2008 Co-Investigator. Isotechnika.“Novel calcineurin inhibitor for de novo renal transplant recipients”

2006-2008 Co-Principal Investigator. iNO Therapeutics.“Inhaled CO in kidney transplantation in swine”

2006-2008 Co-Investigator. iNO Therapeutics.“Renal ischemia reperfusion injury in rats”

2007-2010 Co-Investigator. ViroPharma. “Randomized double-blind study to assess the efficacy and safety of prophylactic use of maribavir versus oral gancyclovir for the prevention of cytomegalovirus disease in recipients of orthotopic liver transplants”

2007-2010 Co-Investigator. Novartis. “A 12-month open-label randomized multi-center sequential cohort dose-finding study to evaluate the efficacy, safety, and tolerability of oral AEB071 versus tacrolimus in combination with Myfortic, Simulect, and corticosteroids in de novo adult renal transplants”

2008-2011 Site Principal Investigator. Ikaria C201.“Placebo-controlled, safety and tolerability study of the effects of carbon monoxide for inhalation in patients receiving kidney transplantation”

2009-2010 Principal Investigator. Harvard Catalyst Pilot Grants Program.“Social networks and socialized risk: Understanding and mitigating disparities in renal transplantation.”

2004-2012 Site Principal Investigator. NIH/NIAID AI052748 “Solid organ transplantation in HIV: Multi-site study”

2008-2012 Co-Investigator. Bayer/Onyx. “Neoadjuvant sorafenib prior to RFA in HCC, a randomized controlled phase II trial”

2011-2012 Site Principal Investigator. Roche Organ Transplantation Foundation“Predicting outcomes with marginal livers after transplantation”

2012 Co-Investigator. ACRIN-6690 (Dana-Farber Cancer Institute) "A prospective, multicenter comparison of multiphase contrast-enhanced CT and multiphase contrast-enhanced MRI for diagnosis of hepatocellular carcinoma and liver transplant allocation"

17


2015-2017 Site Principal Investigator. SPLIT (Studies in Pediatric Liver Transplantation) Database. "Prospective Observational Study to Assess Outcomes in Pediatric LiverTransplant Recipients."

Current Funding:

2016- Co-Investigator. Greenwall Foundation. “The Social Support Criterion in Transplantation: Considerations for Distributive and Procedural Justice.” Keren Ladin, Ph.D., M.Sc. Principal Investigator, Tufts University, Medford, MA.

C. Report of Current Research Activities:

Project RoleReview of liver transplantation for hepatoblastoma (SRTR Registry analysis) PI

Study of outpatient medication errors in transplantation and PIimplementation of systems solutions to reduce the incidence

Mortality and Morbidity Conference – Classification of M&M for Quality PIImprovement

D. Report of Teaching

1. Local ContributionsMedical School

University of Minnesota Health Sciences Center; Minneapolis, MN

1977-1985 Core Clerkship in SurgeryTeaching role: Resident and FellowType of students: Average of 25 UM medical students per yearPreparation and contact time: Average 5-10 hours per week

Washington University School of Medicine; St. Louis, MO

1985-1991 Core Clerkship in SurgeryTeaching role: AttendingType of students: Average of 25 WUSM students per yearPreparation and contact time: Average 2 hours per week

1985-1991 Transplant ElectiveTeaching role: AttendingType of students: Average of 8 WUSM students per yearPreparation and contact time: Average 2 hours per week

University of Cincinnati College of Medicine; Cincinnati, OH

1991-2001 Core Clerkship in SurgeryTeaching role: AttendingType of students: Average of 25 UC medical students per yearPreparation and contact time: Average 2 hours per week

2001 Interactive Teaching SessionsTeaching role: Discussion leader

18


Type of students: Average of 8-10 UC medical students every 2 months rotating on general surgery to discuss specific clinical surgical topics Preparation and contact time: Average 4 hours per week

1991-2001 Transplant ElectiveTeaching role: AttendingType of students: Average of 8 UC medical students per yearPreparation and contact time: Average 2 hours per week

Harvard Medical School; Boston, MA

2001-2012 Core Clerkship in SurgeryTeaching role: AttendingType of students: Average of 10 HMS students per yearPreparation and contact time: Average 2 hours per week

2001-2012 Transplant ElectiveTeaching role: AttendingType of students: Average of 2-4 HMS students per yearPreparation and contact time: Average 2 hours per week

2007 Introduction to the Abdominal Exam (November 19)Teaching role: Faculty memberType of students: 4 second-year HMS studentsPreparation and contact time: 4 hours

2011-2012 Student Tutorial Teaching role: AttendingType of students: 4 third-year HMS students on core surgery clerkshipPreparation and contact time: Preparation and contact time 3 hours per week


2012-2014 Clinical rotation in General Surgery at St. Louis Veterans Administration Medical CenterTeaching role: AttendingType of students: Average of 12 students per yearPreparation and contact time: Average of 2 hours per week

Vanderbilt University School of Medicine; Nashville, TN

2014-2016 Clinical rotation in Hepatobiliary Surgery and Liver TransplantationTeaching role: AttendingType of students: Average of 12 students per yearPreparation and contact time: Average of 1 hour per week


2017-present Clinical rotation in General Surgery at St. Louis Veterans Administration Medical CenterTeaching role: AttendingType of students: Average of 12 students per yearPreparation and contact time: Average of 1-2 hours per week

19


Graduate Medical CoursesUniversity of Minnesota Health Sciences Center; Minneapolis, MN

1977-1985 Surgical teaching to interns and residents on the clinical surgical and transplant services Average of 30 interns and residents per yearPreparation and contact time: Averaged 5-10 hours per week.


1985-1991 Residency Program in General Surgery Samuel A. Wells, M.D., Chairman of Surgery and Program DirectorInstructor for pre- and post-operative care and operative technique to general surgery residents Average of 35 interns and residents per yearPreparation and contact time: Averaged 5-10 hours per week.

1985-1991 ASTS Approved Transplant FellowshipM. Wayne Flye, M.D., Ph.D., Program Director 1985-1988 Douglas W. Hanto, M.D., Ph.D., Program Director 1988-1991Instructor for pre- and post-operative care and operative technique to transplant fellowsAverage of 1-2 fellows per yearPreparation and contact time: Averaged 5-10 hours per week.


1991-2001 Residency Program in General SurgeryJosef E. Fischer, M.D., Chairman of Surgery and Program DirectorInstructor for pre- and post-operative care and operative technique to general surgery residents Average of 35 interns and residents per yearPreparation and contact time: Averaged 5-10 hours per week.

1991-2001 Transplant FellowshipJ. Wesley Alexander, M.D., Sc.D., Program DirectorInstructor for pre- and post-operative care and operative technique to transplant fellowsAverage of 1-2 fellows per yearPreparation and contact time: Averaged 5-10 hours per week.

Beth Israel Deaconess Medical Center; Boston, MA

2001-2012 Residency Program in General SurgeryJosef E. Fischer, M.D., Chairman of Surgery and Program Director (2001-2008)James Hurst, M.D., Acting Chairman of Surgery; Scott Johnson, M.D., Program Director (2008-present)Instructor for pre- and post-operative care and operative technique to general surgery residents Average of 35 interns and residents per yearPreparation and contact time: Averaged 5-10 hours per week.

2001-2012 Transplant Fellowship

20


Douglas W. Hanto, M.D., Ph.D., Program Director (2001-2008) Seth Karp, M.D., Program Director, 2008-2011Amy Evenson, M.D., Program Director, 2011-2012Instructor for pre- and post-operative care and operative technique to transplant fellowsAverage of 1-2 fellows per yearPreparation and contact time: Averaged 5-10 hours per week.

Washington University School of Medicine in St. Louis; St. Louis, MO

2013 Skills lab instruction for open liver resection (March 13, April 10)Teaching role: InstructorType of students: 12 senior residents in general surgeryPreparation and contact time: Preparation and contact time 5 hours

2013 Lecture on open common bile duct explorationTeaching role: LecturerType of students: 30 junior and senior residents in general surgeryPreparation and contact time: 5 hours

St. Louis Veterans Administration Hospital; St. Louis, MO

2012-2014 Residency Program in General Surgery (Washington University School of Medicine)Michael Awad, M.D., Program DirectorInstructor for pre- and post-operative care and operative technique to general surgery residents Average of 24 interns and residents per yearPreparation and contact time: Averaged 5-10 hours per week.

Vanderbilt University School of Medicine; Nashville, TN

2014-2016 Residency Program in General Surgery Kyla Terhune, M.D., Program DirectorInstructor for pre- and post-operative care and operative technique to general surgery residents Average of 24 interns and residents per yearPreparation and contact time: Averaged 5 hours per week.

St. Louis Veteran’s Administration Health Care System; St. Louis, MO

2017-present Residency Program in General Surgery (Washington University School of Medicine and St. Louis University School of Medicine)Paul Wise, M.D., Program Director (WU)Kate Wittgen, M.D., Program Director (SLU)Instructor for pre- and post-operative care and operative technique to general surgery residents Average of 48 interns and residents per yearPreparation and contact time: Averaged 5-10 hours per week.

21


Local invited teaching presentations


1986 Lecturer. 1986-1991. “Portal Hypertension”; 3rd Year Medical Students on Surgical Services; Lecture given every 2 months to approximately 15 students each rotation as part of their core surgical curriculum. Preparation and contact time: Approximately 4 hrs.

1988 Lecturer. 1988-1991. “Organ Transplantation”; 3rd Year Medical Students on Surgical Services; Lecture given every 2 months to approximately 15 students each rotation as part of their core surgical curriculum. Preparation and contact time: Approximately 4 hrs.

Lecturer. Surgical Seminar; “Cirrhosis of the Liver”; Barnes Hospital, St. Louis, MO; May 16.

Lecturer. Surgical Seminar; “Cirrhosis of the Liver”; Barnes Hospital, St. Louis, MO; August 22.

Lecturer. Pediatric Grand Rounds; “Transplantation in Children”; St. Louis Children’s Hospital, St. Louis, MO; September 2.

Lecturer. Surgery Grand Rounds; “Posttransplant Lymphoproliferative Disorders”; Barnes Hospital; St. Louis, MO; September 14.

Lecturer. Surgery Grand Rounds; “Hepatic Transplantation: Indications, Technique, and Results”; Jewish Hospital; St. Louis, MO; October 4.

Lecturer. Grand Rounds; “Liver Transplantation Indications, Results, and Complications”; St. Joseph’s Hospital; Kirkwood, MO; October 12.

Invited Speaker. St. Louis Metropolitan Society of Critical Care Medicine Meeting; “Resuscitation of the Organ Donor”; St. Louis, MO; October 29.

Lecturer. Grand Rounds; “Current Topics in Renal Transplantation”; St. John’s Mercy Medical Center, St. Louis, MO; November 10.

Lecturer. Citywide Infectious Disease Conference. “Neoplastic Complications of EBV Infection”; St. Louis, MO; December 13.

1989 Lecturer. Internal Medicine Grand Rounds; “Current Status of Renal Transplantation”; St. Louis Regional Medical Center, St. Louis, MO; January 17.

Lecturer. Surgery Grand Rounds; “Monoclonal Antibody Therapy in Renal Transplantation”; Washington University School of Medicine, Department of Surgery, St. Louis, MO; April 5.

Lecturer. Grand Rounds; “Liver Transplantation”; St. Louis Veteran’s Administration Hospital, St. Louis, MO; November 8.

1990 Lecturer. Urology Grand Rounds; “Current Topics in Renal Transplantation”; Washington University School of Medicine, Division of Urology, St. Louis, MO; January 20.

22


Lecturer. Surgery Grand Rounds; “Cancer After Organ Transplantation”; Washington University School of Medicine, Department of Surgery, St. Louis, MO; March 23.

Lecturer. Grand Rounds; “Liver Transplantation”; St. Luke’s Hospital, St. Louis, MO; April 24.


1991 Lecturer. 1991-1999. “Organ Transplantation”; 3rd Year Medical Students on Surgical Services; Lecture given every 2 months to approximately 15 students each rotation as part of their core surgical curriculum. Preparation and contact time: Approximately 4 hrs.

1993 Lecturer. 1993-2001. “Transplant Immunology: Clinical Correlation”; Lecturer; 2nd Year Medical Students; Lecture given once per year to 100 students to bring clinical relevance to Medical Microbiology and Immunology Course. Preparation and contact time: Approximately 4 hrs.

1995 Lecturer. 1995-2001. “Surgical Diseases of the Liver”; 3rd Year Medical Students on Surgical Services; Lecture given every 2 months to approximately 15 students each rotation as part of their core surgical curriculum. Preparation and contact time: Approximately 4 hrs.

1991 Invited speaker. Surgical Grand Rounds; “Benign Liver Masses: Diagnosis and Management”; Miami Valley Hospital, Dayton, OH; October 12.

Lecturer. Surgical Grand Rounds; “Liver Transplantation: Who, When, and How - And Then What?”; University of Cincinnati, Cincinnati, OH; November 14.

1992 Lecturer. Medical Alumni Meeting, University of Cincinnati College of Medicine; “The Adult Liver Transplant Program: Bench Surgery and Liver Transplantation for Tumors”; University of Cincinnati, Cincinnati, OH; May 15.

Lecturer. Medicine Grand Rounds; “Liver Transplantation”; Providence Hospital, Cincinnati, OH; June 18.

Lecturer. Surgical Grand Rounds; “Liver Transplantation”; Bethesda North Hospital, Cincinnati, OH; September 17.

Lecturer. Basic Science Lecture Series; “Immunology”; University of Cincinnati, Department of Surgery, Cincinnati, OH; November 14.

1993 Lecturer. Medical Staff Grand Rounds; “Changing Indications for Liver Transplantation”; Drake Center, Cincinnati, OH; January 27.

Invited speaker. American Association of Critical-Care Nurses, Greater Cincinnati Chapter, Fifth Annual Critical Care Conference; “Liver Transplantation”; Cincinnati Marriott, Cincinnati, OH; April 23.

Invited speaker. American Society for Histocompatibility and Immunogenetics Midwest Regional Meeting; “Post-Transplant Clinical Complications”; Great Southern Hotel, Columbus, OH; May 7.

23


Lecturer. Grand Rounds; “Metastatic Malignancies of the Liver”; University of Cincinnati, Cincinnati, OH; June 9.

1994 Lecturer. Clinical and Experimental Immunology Seminar; “Vβ Restriction in Alloreactivity”; Children’s Hospital Medical Center, Cincinnati, OH; December 15.

1995 Lecturer. Surgical Grand Rounds. “Changing Indications for Liver Transplantation”; The Christ Hospital, Cincinnati, OH; March 2.

1996 Lecturer. Mont Reid Surgical Society; “Management of Benign and Malignant Bile Duct Strictures”; University of Cincinnati, Department of Surgery, Cincinnati, OH; May 17.

2000 Lecturer. Mont Reid Surgical Society; “Evaluation and Treatment of Bile Duct Injuries and Benign Strictures”; University of Cincinnati, Department of Surgery, Cincinnati, OH; May 19.

Harvard Medical School; Boston, MA

2002 Lecturer. “Liver Failure and Liver Transplantation”; 3rd Year Medical Students on Surgical Services. Preparation and contact time: Approximately 4 hrs.

Lecturer. Grand Rounds; “Update in Liver Transplantation”; Department of Anesthesia and Critical Care, Beth Israel Deaconess Medical Center, Boston, MA; May 1.

Lecturer. Medical Grand Rounds; “Liver Transplantation: Problems Solved and Unsolved”; Beth Israel Deaconess Medical Center, Boston, MA; September 19.

Lecturer. BIDMC Conference on New Horizons in Hepato-Pancreatico-Biliary Disease; “Technical Caveats of Hepatic Resection”; Boston, MA; December 7.

2003 Lecturer. Surgical Grand Rounds; “Management of Bile Duct Strictures”; Mount Auburn Hospital, Cambridge, MA; February 11.

Lecturer. Surgical Grand Rounds; “Clinical Crossroads: A 50 Year Old Man Awaiting Transplant”; Beth Israel Deaconess Medical Center, Boston, MA; March 26.

Lecturer. Grand Rounds; “Transplantation 2003”; Beth Israel Deaconess Medical Center, Department of Anesthesia, Boston, MA; June 11.

Lecturer. Surgical Grand Rounds; “Liver Transplantation: Problems Solved and Unsolved”; Brigham and Women’s Hospital, Boston, MA; September 10.

Lecturer. Grand Rounds; “Liver Transplantation for the General Internist”; Cambridge Hospital, Cambridge, MA; October 29.

2004 Lecturer. Transplant Conference; “State of the Transplant Center”; Beth Israel Deaconess Medical Center, Boston, MA; April 6.

2005 Lecturer. Transplant Conference; “Liver and Intestinal Transplantation: Summary Analysis of Data from the SRTR (Scientific Registry of Transplant Recipients) 1994-2003”; Beth Israel Deaconess Medical Center, Boston, MA; February 8.

24


Invited speaker. Harvard-MIT Division of Health Sciences and Technology, BioMatrix Program; “Ethical Issues in Transplantation”; BioMatrix Members’ Meeting “Whose Organ Is It, Anyway?”; Massachusetts Institute of Technology, Cambridge, MA; October 18.

2006 Lecturer. Transplant Conference; “ECD and DCD Organ Transplantation in New England: Unique Problems and Solutions"; Beth Israel Deaconess Medical Center, Boston, MA; March 7.

Lecturer. Surgical Research Seminar; “Cytoprotection and its Potential Applications in Clinical Transplantation”; Beth Israel Deaconess Medical Center, Boston, MA; May 15.

Lecturer. Transplant Research Conference; “Cytoprotection: Future Possibilities in Transplantation”; Beth Israel Deaconess Medical Center, Boston, MA; May 16.

Lecturer. Surgical Grand Rounds; “Expanding Organ Donation through Extended Criteria Donors and Donors after Cardiac Death”; Beth Israel Deaconess Medical Center, Boston, MA; July 19.

2008 Lecturer. Beth Israel Deaconess Medical Center Physician Appreciation Day; “Update on Transplantation”; Cambridge, MA; March 15.

Lecturer. Resident Seminar; “Benign Liver Lesions”; Beth Israel Deaconess Medical Center; Boston, MA; April 1.

Lecturer. Resident Seminar; “Malignant Liver Lesions”; Beth Israel Deaconess Medical Center; Boston, MA; April 8.

Invited Speaker. Grand Rounds; “Ethical Issues in Transplantation”; Beth Israel Deaconess Hospital-Needham; Needham, MA; October 15.

2009 Lecturer. Grand Rounds; “Protective Effects of Carbon Monoxide”; Department of Anesthesia, Beth Israel Deaconess Medical Center; Boston, MA; April 1.

Invited Speaker. Research and Academic Affairs All Staff Meeting; “Protective Effects of Carbon Monoxide”; Beth Israel Deaconess Medical Center; Boston, MA; May 1.

Invited Speaker. Grand Rounds; “Carbon Monoxide in Health and Disease.” Department of Surgery, Beth Israel Deaconess Medical Center; Boston, MA; September 23.

Lecturer. Tumor Board for Oncology Fellows; “Case Presentations: Surgical Management of Metastatic Colon Cancer to the Liver.” Division of Hematology-Oncology, Beth Israel Deaconess Medical Center; Boston, MA; November 23.

2010 Lecturer. Transplant Conference; “Outcomes of the National HIV-TR Study (Part 1): Kidney Transplantation.” The Transplant Institute, Beth Israel Deaconess Medical Center; Boston, MA; March 30.

Invited Speaker. Transplant Lecture; “The Protective Effects of Carbon Monoxide in Health, Disease, and Transplantation.” Department of Surgery, Massachusetts General Hospital; Boston, MA; April 5.

25


Lecturer. Resident Curriculum Conference; “Benign Liver Lesions.” Department of Surgery, Beth Israel Deaconess Medical Center; Boston, MA; April 12.

Lecturer. Transplant Conference; “Outcomes of the National HIV-TR Study (Part 2): Liver Transplantation.” The Transplant Institute, Beth Israel Deaconess Medical Center; Boston, MA; October 5.

2011 Invited Speaker. Chinese Executive Hospital Management Leadership Program 2011 (CEHMLP); Xuejun Kong, M.D., Co-Director. "Transplant Centers of Excellence." Beth Israel Deaconess Medical Center; Boston, MA; November 3.

2012 Invited Speaker. Surgery Grand Rounds; "A Decade of Transplantation at BIDMC – 2001-2011." Department of Surgery, Beth Israel Deaconess Medical Center; Boston, MA; January 18.

Invited Speaker. Surgery Leadership Council; "A Decade of Transplantation at BIDMC – 2001-2011." Department of Surgery, Beth Israel Deaconess Medical Center; Boston, MA, February 1.

Lecturer. Perspective Lecture for 4th-year Harvard Medical School students; "What Is an Intern Anyway?". HMS/BIDMC Surgical Bootcamp Course (Alok Gupta, MD, Director). Beth Israel Deaconess Medical Center; Boston, MA; April 3.

Lecturer. Transplant Conference; "Uncontrolled donation after circulatory determination of death." The Transplant Institute, Beth Israel Deaconess Medical Center; Boston, MA; May 1.

Washington University School of Medicine, St. Louis

2014 Invited Speaker. Transplant Conference. “Kidney and Liver Transplantation in HIV+ Patients: Results from an NIH Funded Multicenter Trial.” St. Louis University, St. Louis, MO; August 26.

Vanderbilt University School of Medicine, Nashville, TN

2014 Invited Speaker. Surgical Team Conference. “Pediatric Liver Transplantation”. Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, TN; November 12.

2015 Invited Speaker. PICU Extravaganza. “Pediatric Liver Transplantation”. Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, TN; April 27.

2016 Invited Speaker. Surgical Grand Rounds. “Patient Safety Begins with Me”. Vanderbilt University Medical Center, Nashville, TN; January 29.

Continuing Medical Education Courses

1992 Invited Speaker. 29th Regional Meeting of Ohio Society of Gastrointestinal Nurses and Associates “Liver Transplantation”; Sponsored by Ohio Nurses Association, Miami Valley Hospital, Dayton, OH; October 17.

26


1993 Invited Speaker. 5th Annual Critical Care Symposium; “Liver Transplantation”; Greater Cincinnati Chapter American Association of Critical Care Nurses, Cincinnati, OH; April 23.

1994 Invited Speaker. Dayton Gastroenterology Symposium for Primary Care Physicians; “Liver Transplantation 1994”; Sponsored by Wright State University School of Medicine, Department of Medicine, Dayton, OH; November 12.

1995 Invited Speaker. Controversies in the Multi-disciplinary Approach to Pancreaticobiliary Diseases Symposium; Debates in Gastroenterology: “Invasive Klatskin Tumors Should be Managed Surgically”; “Advances in the Diagnosis and Management of Benign and Malignant Biliary Strictures: Surgical Options”; Sponsored by Division of Digestive Diseases, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH; September 23-24.

Invited Speaker. Hepatitis and Liver Disease 1995; “Update on the Surgical Management of Variceal Bleeding”; Sponsored by the Liver Unit at the University of Cincinnati and the Department of Continuing Medical Education, Cincinnati, OH; December 2.

1998 Invited Speaker. Wright State University Department of Surgery 21st Annual Postgraduate Course “Selected Topics in Hepatobiliary Tract Disease”; “Surgical Treatment of Benign Liver Lesions”; “Acute and Chronic Liver Failure and the Indications for Liver Transplantation”; Dayton, OH; October 7.

2000 Invited Speaker. University of Cincinnati College of Medicine Mini-Medical College; “Transplantable Spare Parts”; Cincinnati, OH; October 17.

2002 Invited Speaker. Beth Israel Deaconess Medical Center Department of Nursing Critical Care Conference; “Liver Disease: Medical Treatment Leading to Surgical Treatment”; Boston, MA; April 23.

Invited Speaker. Beth Israel Deaconess Medical Center Department of Nursing Liver Transplant Clinic; “Post-operative Management of Liver Transplant Patients”; Boston, MA; June 18.

2003 Invited Speaker. UNOS Region 1 Transplant Coordinators’ Meeting; “Maximizing Liver Donation – Donor and Recipient Factors”; Wyndham Westborough Hotel, Westborough, MA; March 25.

2005 Invited Speaker. UNOS Region 1 Clinical Forum; “Ethical Controversies Facing Transplantation in 2005”; Beechwood Hotel, Worcester, MA, April 26.

2006 Invited Speaker. Beth Israel Deaconess Medical Center Transplant Update Course for Nurses. “Living and Deceased Donor Criteria”; Boston, MA; December 12.

2007 Invited Speaker. Joslin Diabetes Center. Advances in Diabetes 2007. “Pancreas Transplantation; Boston, MA; November 3.

27


Invited Speaker. Harvard Medical International and Wockhardt Hospitals CME. “Current Status of Organ Transplantation and Future Trends.” Mumbai, India; November 12.

Invited Speaker. Harvard Medical International and Wockhardt Hospitals CME. “Current Status of Organ Transplantation and Future Trends.” Bangalore, India; November 15.

2008 Lecturer. “Advanced Course in Liver Diseases.” Harvard Medical School and Beth Israel Deaconess Medical Center. “Surgical Considerations in the Management of Portal Hypertension.” Boston, MA; January 16-18. Invited Speaker. Joslin Diabetes Center and Beth Israel Deaconess Medical Center Physician Appreciation Day. “Transplantation Update.” Boston, MA; March 15.

Lecturer. “Advanced Course in Liver Diseases.” Harvard Medical School and Beth Israel Deaconess Medical Center. “Surgical Considerations in the Management of Portal Hypertension.” Boston, MA; April 16-18.

Advisory and supervisory responsibilities in clinical or laboratory setting

1988-1991 Director, Section of TransplantationDepartment of SurgeryWashington University School of Medicine; St. Louis, MOAdvise and supervise 35 interns/residents on clinical transplant rotations each year along with 1-2 clinical transplant fellows per yearPreparation and contact time: 5 hours per week

1985-1991 PI, Transplant Immunology Laboratory Washington University School of Medicine; St. Louis, MO

Advise and supervise 1 post-doctoral fellow or surgical resident per yearPercent time devoted to the laboratory: 25%

1991-2001 Director, Liver Transplant Program, University of Cincinnati College of Medicine; Cincinnati, OH Advise and supervise 35 interns/residents on clinical transplant rotations as

well as 1 clinical transplant fellow per year Preparation and contact time: 5-10 hours per week

1991-1995 PI, Transplant Immunology Laboratory University of Cincinnati College of Medicine; Cincinnati, OH Advise and supervise 1 post-doctoral fellow or surgical resident per year. Per cent time devoted to the laboratory: 25%

2001-2012 Chief, Division of TransplantationBeth Israel Deaconess Medical Center and Harvard Medical School; Boston, MA Advise and supervise 35 interns/residents on clinical transplant rotations as well as 1 clinical transplant fellow per yearPreparation and contact time: 5-10 hours per week

2012-2014 Program Director, General Surgery

28


St. Louis Veterans Administration HospitalSt. Louis, MO Advise and supervise 24 interns/residents on general surgery rotationsPreparation and contact time: 5-10 hours per week

Teaching leadership role in department and medical school

1988-1991 Director, ASTS Approved Transplant Surgery Fellowship Washington University School of Medicine; St. Louis, MO Responsible for recruitment, training, and certification of transplant surgery fellows

2001-2008 Director, ASTS Approved Transplant Surgery Fellowship Beth Israel Deaconess Medical Center; Boston, MA Responsible for recruitment, training, and certification of

transplant surgery fellows

Names of advisees or trainees

Duration of Training Name Current Position

Washington University School of Medicine1985-1986 Martin D. Jendrisak, M.D. Medical Director and Vice President of

Research and Development, Gift of Hope Organ & Tissue Donor Network, Itasca,

IL1986-1987 Norman Kneteman, M.D. Professor of Surgery, University of Alberta;

Regional Program Clinical Director of Transplantation at Capital Health Authority; Edmonton, Alberta

1986-1988 Eric S. Berens, M.D. Private practice, general and vascular general surgery; Tucson, AZ

1987-1988 Chris S. McCullough, M.D. Transplant surgeon, Jacksonville MemorialHospital; Jacksonville, FL

1988-1990 Mark W. Shelton, M.D. Private practice, general and vascular surgery; Columbia, TN

1988-1990 Lloyd E. Ratner, M.D. Chief, Kidney and Pancreas Transplantation; Professor of Surgery, Columbia University; New York, NY

1989-1991 Kiichiro Uchiyama, M.D. Assistant Professor of Surgery, Nippon Medical School; Chairman of Surgery, Ebina General Hospital; Ebina, Japan

University of Cincinnati College of Medicine1991-1993 Maria H. Alonso, M.D. Associate Professor of Pediatric Surgery,

Surgical Director, Kidney Transplant Program, Co-Surgical Director, Intestinal Transplant Surgery, Children’s Hospital Medical Center; Cincinnati, OH

29


1992-1994 William F. Marterre, M.D. Private practice, general surgery; Winston-Salem, NC

1993-1995 John F. Valente, M.D. Private practice, general surgery; Alabama1993-1994 Steve I. Rossi, Pharm.D. President and Principal at SJR Healthcare

Consulting, Incorporated,San Francisco, CA

1994-1995 Martha A. Ferguson, M.D. Private practice, colon and rectal surgery; Atlanta, GA

1996-1998 Annie Fecteau, M.D. Staff surgeon, Hospital for Sick Children of Toronto; Professor of Surgery, University of Toronto; Toronto, Ontario, Canada

1999-2001 Scott R. Johnson, M.D. General surgeon, St. Elizabeth's Medical Center, Boston, MA

2000-2001 Greg M. Tiao, M.D. Richard and Geralyn Azizkhan Professor andand Chair in Pediatric Surgery, Surgical Director, Liver TransplantationAssociate Director, Pediatric Surgery Fellowship, Children’s Hospital Medical Center; Cincinnati, OH

Beth Israel Deaconess Medical Center2001-2002 Mohamed Akoad, M.D. Attending transplant surgeon, Lahey Clinic,

Burlington, MA2003-2004 Charudutt Paranjape, M.D. Trauma and Critical Care Surgeon, Akron

Akron General Hospital, Akron, OH2003-2005 Charles F. Bratton, M.D. Assistant Professor of Surgery,

Medical University of South Carolina; Charleston, SC

2006-2007 Myung Hee Yoon, M.D. Assistant Professor of Surgery, Gospel Hospital, Kosin University College of Medicine; Busan, South Korea

2006-2008 Lena Sibulesky, M.D. Assistant Professor of Surgery,University of Washington, Seattle, WA

2007-2012 Keren Ladin, Ph.D., M.Sc. Department of Occupational Therapy and the Lab for Research Ethics, Aging, and CommunityHealth (REACH Lab), Assistant Professor,Tufts University, Medford, MA

2008-2009 Kris Croome, M.D., M.P.H. Assistant Professor of Surgery, Mayo Clinic, Jacksonville, FL.Recipient of Western Ontario Travel Award for Clinical Research.

2008-2010 Kaori Kuramitsu, M.D., Ph.D. Attending Staff, Kobe University Graduate School of Medicine, Department of Surgery,Division of Hepato-Biliary-Pancreatic Surgery, Kobe, Japan; Recipient of Rising Star Young Investigator Award, ILTS 16th Annual Congress, Hong Kong, June 16-19, 2010. Presidential Poster of Distinction: 2011 AASLD.

2010-2012 Kristin E. Raven, M.D. Attending Transplant Surgeon, The Transplant Institute, Beth Israel Deaconess Medical

Center;

30


Instructor in Surgery, Harvard Medical School

2. Regional, national, or international contributions

Invited Presentations

Regional1988 Invited Speaker. Mid-America Transplant Services Symposium on Organ Donation; “Donor

Management”; St. Bernard’s Regional Medical Center, Jonesboro, AR; September 29.

1989 Invited Speaker. Pediatric Grand Rounds; “Current Status of Pediatric Transplantation”; The Children’s Mercy Hospital, Kansas City, MO; May 11.

Invited Speaker. Clinical Transplantation Symposium; “Monoclonal and Polyclonal Antibody Induction in Renal Transplantation”; Research Medical Center, Kansas City, MO; October 6.

1990 Invited Speaker. Surgery Grand Rounds; “A Prospective Randomized Comparison of Prophylactic OKT3 vs. ALG in Cadaver Renal Transplant Recipients”; University of Kansas, Kansas City, KS; April 11.

Invited Speaker. Grand Rounds; “Benign Liver Masses: Diagnosis and Management”; Miami Valley Hospital, Dayton, OH; October 12.

1992 Invited Speaker. Grand Rounds; “Changing Indications for Liver Transplantation”; Holzer Clinic, Gallipolis, OH; June 5.

1993 Invited Speaker. 50th Annual Meeting of Central Surgical Association; “T-cell Receptor Usage in Acute and Chronic Allograft Rejection”; University of Cincinnati Medical Center, Cincinnati, OH; March 4.

Invited Speaker. Midwest American Society for Histocompatibility and Immunogenetics Regional Meeting; “Post-transplant Clinical Complications”; Ohio State University, Columbus, OH; May 17.

1996 Invited Speaker. Grand Rounds; “Liver Resection for Benign and Malignant Diseases”; Holzer Clinic, Gallipolis, OH; May 10.

1998 Invited Speaker. 43rd Annual Meeting of the Ohio Chapter of the American College of Surgeons; “Cryo Surgery for Hepatic Tumors”; Columbus, OH; May 8.

2001 Visiting Professor. Cleveland Surgical Society Visiting Professor; “Surgical Management of Extrahepatic Cholangiocarcinoma”; Cleveland Surgical Society, Cleveland, OH; April 3.

2002 Lecturer. Grand Rounds; “Liver Transplantation: Problems Solved and Unsolved”; Leonard Morse Hospital, Natick, MA; September 30.

Lecturer. Grand Rounds; “Liver Transplantation: Problems Solved and Unsolved”; South Shore Hospital, Weymouth, MA; October 29.

2003 Invited Speaker. Grand Rounds; “Liver Transplantation: Problems Solved and Unsolved”; Maine Medical Center, Portland, ME; February 13.

31


Lecturer. Surgical Grand Rounds; “Management of Laparoscopic Bile Duct Injuries”; St. Luke’s Hospital, New Bedford, MA; April 12.Lecturer. Grand Rounds; “New Innovations in Transplantation”; Falmouth Hospital, Falmouth, MA; August 12.

2004 Invited Speaker. Grand Rounds; “Transplant Strategies”; Lowell General Hospital, Lowell, MA; May 12.

2006 Invited Speaker. Lecture; “Multimodality Management of Hepatocellular Carcinoma: Who Gets What”; Rhode Island GI Society, Providence, RI; June 15.

2007 Invited Speaker. Grand Rounds; “Treatment Options for Hepatocellular Carcinoma”; Baystate Medical Center; Springfield, MA; October 25.

Lecturer. Grand Rounds; “Organ Donation and Transplantation: The Good, the Bad, and the Ugly”; Lowell General Hospital, Lowell, MA; March 7.

Keynote Speaker. “The Intersection of Patients’ Needs, Economics, and Ethics in Organ Donation and Transplantation”; MIT Hippocratic Society Conference - “The Organ Trail: The Science and Ethics of Tissue Engineering, Transplantation and Organ Trafficking”; Massachusetts Institute of Technology, Cambridge, MA; March 10.

Lecturer. Grand Rounds; “Transplant Update”; MetroWest, Leonard Morse Hospital, Natick, MA; April 23.

Lecturer. Grand Rounds; “Update: Kidney, Liver, and Pancreas Transplantation"; Saint Vincent Hospital, Worcester, MA; May 17.

Lecturer. Transplant Conference; “When to Say No to Transplantation”; Baystate Medical Center, Springfield, MA; November 27.

2008 Invited Speaker. Grand Rounds; “Liver Transplantation”; Exeter Medical Center; Exeter, NH; May 20.

Invited Speaker. Grand Rounds; “Hepatocellular Carcinoma: From Epidemiology to Transplant”; Caritas St. Elizabeth’s Hospital; Brighton, MA; September 25.

2009 Invited Speaker. Medical Grand Rounds; “Transplantation: State of the Art (and Science)”; Saint Vincent Hospital; Worcester, MA; January 29.

Invited Speaker. Medical Grand Rounds; “Ethical Issues in Transplantation”; Saints Medical Center; Lowell, MA; April 2.

2016 Invited Speaker. Pediatric Grand Rounds; “Overview of Pediatric Liver Transplantation”; Niswonger Children’s Hospital; Johnson City, TN; September 26.

National1983 Invited Speaker. American Cancer Society Science Writers' Seminar Participant and Lecturer;

“Epstein-Barr Virus Induced B-cell Lymphoma after Kidney Transplantation”; American Cancer Society, San Diego, CA.

32


1988 Invited Speaker. American Society of Transplant Physicians Consensus Conference; “Prophylactic Use of Monoclonal Antibodies in Renal Transplantation”; St. Louis, MO; November 2.

1989 Invited Speaker. Transplant Grand Rounds; “OKT®3 and Minnesota ALG in Renal Transplantation”; Dallas Transplant Institute, Dallas, TX; March 21.

Invited Speaker. Society of Clinical Surgery Meeting; “EBV Related Lymphoproliferative Diseases after Transplantation”; St. Louis, MO; November 3.

1990 Invited Speaker. Grand Rounds; “Prophylactic Use of OKT®3 in Transplantation”; University of New York, Syracuse; Syracuse, New York; May 4.

1991 Invited Speaker. Nephrology Grand Rounds; “Viral Infections in Transplant Patients”; St. Francis Medical Center, Tulsa, OK; November 11.

1992 Invited Speaker. Transplant Conference; “Posttransplant Epstein-Barr Virus Related Lymphoproliferative Diseases”; Porter Memorial Hospital, Denver, CO; April 3.

Faculty. Ortho Biotech Training School; “Transplantation Immunology”; Ortho Biotech, Raritan, NJ; April 7.

Invited Speaker. Multidisciplinary Transplantation Conference; “Clonality of EBV-Related Lymphoproliferative Disease in Transplant Recipients: Implications for Treatment”; University of California San Francisco, San Francisco, CA; September 30.

1993 Invited Speaker. Surgical Grand Rounds; “Clonality of Post-Transplant Lymphoproliferative Diseases in Transplant Recipients: Implications for Treatment”; Yale Medical School, New Haven, CT; January 9.

Invited Speaker. Central Surgical Association 50th Annual Meeting; “T-Cell Receptor Usage in Acute and Chronic Allograft Rejection”; University of Cincinnati Medical Center, Cincinnati, OH; March 4.

Invited Speaker. Eighth Annual Meeting: Clinical Applications of Cytometry; “Overview of Monitoring the Transplant Recipient”; Charleston, SC; August 12.

Faculty. Ortho Biotech Training School; “Transplantation Immunology”; Ortho Biotech, Raritan, NJ; August 13.

1994 Invited Speaker. Transplant Pathology Review Conference; “Spectrum of Post-Transplant EBV Related Lymphoproliferative Diseases and Implications for Therapy”; Swedish Medical Center, Seattle, WA; April 27.

1995 Invited Speaker. Controversies in Transplant Infection; “PTLD: Role of Current and Future Therapies”; University of Iowa College of Medicine and Mayo Clinic, Tucson, AZ; February 5.

Invited Speaker. Surgical Grand Rounds; “Current Outcomes in Liver Transplantation”; University of South Carolina School of Medicine, Columbia, SC; September 29.

Faculty. Ortho Biotech Training School; “Transplantation Immunology”; Ortho Biotech, Raritan, NJ; November 2.

33


Invited Speaker. Southern Area Regional Transplant Symposium; “OKT3 Induction in Liver Transplantation”; Carolinas Medical Center, Charlotte, NC; December 1.

1996 Invited Speaker. Transplant Conference; “OKT3 Prophylaxis in Liver Transplantation”; Oregon Health Sciences University, Portland, OR; June 20.

Invited Speaker. Transplant Conference; “OKT3 Induction in Liver Transplantation: Role for Low Dose Therapy?”; University of Nebraska, Omaha, NE; October 24.

2001 Visiting Professor. Research Seminar Series; “To Induce or Not to Induce; Monoclonal Antibody Prophylaxis in Liver Transplantation”; Institute for Cellular Therapeutics, University of Louisville Health Sciences Center, Louisville, KY; February 7.

Visiting Professor. Cleveland Surgical Society; “Management of bile duct injuries after laparoscopic cholecystectomy”; Cleveland, OH; April 3.

Visiting Professor. Surgical Grand Rounds; “Lessons Learned from Adult Living Related Donor Right Lobe Liver Transplantation”; Case Western Reserve University, Department of Surgery, Cleveland, OH; April 4.

2003 Invited Speaker. UMN Fellows’ Symposium; “The Saga of PTLD”; University of Minnesota, Department of Surgery, Minneapolis, MN; November 8.

2004 Invited Speaker. UMN Transplant Conference; “Malignancies and Transplantation, Before and After: What We Know and Don’t Know”; University of Minnesota, Department of Surgery, Minneapolis, MN; February 18.

Invited Speaker. The Halsted Society 78th Annual Meeting; “Pursuit of a Peaceful Death in the Face of Technology”; Stanford University, Stanford, CA; September 11.

2005 Visiting Professor. Charles Witte Legacy Lecture; “Translational Research: What Is It?”; University of Arizona, Department of Surgery, Tucson, AZ; March 2.

Visiting Professor. The Medical Student Research Program Seminar; “The Surgeon as Translational Scientist: Bench to OR. Adventures of a UA Medical Student/Researcher: From Tucson to Boston”; University of Arizona, Department of Surgery, Tucson, AZ; March 2.

2006 Invited Speaker. ASTS Winter Basic Science Course; “Human Use Ethics”; Scottsdale, AZ, January 19.

Lecturer. Grand Rounds Lecture; “New Innovations in Transplantation”; Milton Hospital, Milton, MA; June 20.

Panelist. Association of Organ Procurement Organizations; Annual Meeting. Town Hall Forum on Public Solicitation. Boston, MA; June 23.

Visiting Professor. Mayo Clinic Grand Rounds. “Experience with ECD and DCD organs in New England: what are the outer limits?”; Rochester, MN; June 26.

34


Invited Speaker. Transplantation Administration and Transplant Executive Physician Workshop. “Transplant Physician Leadership: Critical Success Factors in Leading a Transplant Center”; San Diego, CA; October 16.

2007 Invited Speaker. American College of Surgeons 93rd Annual Clinical Congress, GS23: Evidence-Based Care for Patients with Acute Upper Gastrointestinal Hemorrhage, “Surgical Considerations in the Management of Portal Hypertension”; New Orleans, LA; October 8.

Invited Speaker. “Transplant Immunosuppression 2007: The Ongoing Search for Improvement”, University of Minnesota. “When to Say ‘No’ to Transplantation”; Minneapolis, MN; October 18.

Invited Speaker. “Transplant Immunosuppression 2007: The Ongoing Search for Improvement”, University of Minnesota. “Pretransplant Malignancy: When is it Acceptable to Transplant”; Minneapolis, MN; October 18.

2008 Invited Speaker. ASTS Winter Symposium: “The High Risk Recipient”. Pre-meeting symposium: “Preparation for a career in Transplantation.” “Managing your Time and Creating Margin”; Marco Island, FL; January 24.

Invited Speaker. “Frontiers of Ethics in Transplantation: Dilemmas and Struggles.” Northwestern University Feinberg School of Medicine, Academy of Psychosomatic Medicine, the American Society of Transplant Surgeons, and the Chicago Transplant Ethics Consortium. “Ethical Challenges Posed by the Solicitation of Deceased and Living Organ Donors.” Chicago, IL; April 4-6.

Invited Speaker. “DDW; AASLD Research Highlights: Hepatobiliary Surgery and Liver Transplantation.” DDW 2008. San Diego, CA; May 17.

2009 Invited Speaker. “Non-Heart-Beating Donors for Liver Transplantation: Will it Address the Donor Shortage?” State of the Art Lecture. DDW 2009. Chicago, IL; May 31.

Visiting Professor. “Ethics and Transplant.” Department of Surgery, Medical University of South Carolina, Charleston, SC; June 8-9.

Invited Speaker. “The Role of the Surgeon in Patients with Hepatobiliary Cancer.” AASLD/ASGE Endoscopy Course. The Liver Meeting (AASLD Annual Meeting), Boston, MA; October 30.

2010 Invited Speaker. “Staging and Surgical Considerations.” Cholangiocarcinoma: A Need to Standardize Tumor Classification? Hepatobiliary Surgery Interest Group. Course Directors: Tushar Patel, M.D. and Greg Gores, M.D. The 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Boston, MA; October 29-November 2.

2011 The Neil Lempert, M.D. Visiting Professorship Lecture. “Beneficial Biologic Effects of Inhaled Carbon Monoxide (CO) in Transplantation.” Department of Surgery and Division of Transplantation, Albany Medical College, Albany, NY; June 2.

Invited Speaker. "Experience with Carbon Monoxide (CO): from Animals to Humans." Animal Models of IRI, DGF, SGF Session, FDA Workshop: "Ischemia reperfusion injury and down stream effects of delayed graft function, other short term and long term outcomes in kidney transplantation." Silver Spring, MD; September 9.

35


2012 Visiting Professor. "Beneficial Biologic Effects of Inhaled Carbon Monoxide (CO) in Transplantation." Surgery Grand Rounds, Department of Surgery, Tulane University, New Orleans, LA; May 4.

Invited Speaker. "Beneficial Biologic Effects of Inhaled Carbon Monoxide in Transplantation". Transplant Conference, Department of Surgery, Washington University Medical Center, St. Louis, MO; May 16.

Invited Speaker. "Treatment Strategies to Mitigate DGF." Session: Transplantation in Depth: Delayed Renal Allograft Function: Pathogenesis, Prevention and Management. American Transplant Congress, Boston, MA; June 3.

2014 Invited Speaker. “Patient Safety and Transplantation.” Session: Lunch and Learn. American Society of Transplant Surgeons 14th Annual State of the Art Winter Symposium, Miami, FL; January 25.

2015 Invited Speaker. Organ Sharing, Delayed Graft Function, and Inhaled Carbon Monoxide: A Bench to Bedside Case Study. National Academies of Sciences, Engineering, Medicine. Health and Medicine Division. Meeting on Organ Donor Intervention, Washington DC, July 14.

2016 Invited Speaker. Organ Sharing, Delayed Graft Function, and Carbon Monoxide: A Bench to Bedside Case Study. CTI Clinical Trials and Consulting, Cincinnati, OH. September 27.

2016 Invited Speaker. Organ Sharing, Delayed Graft Function, and Inhaled Carbon Monoxide: A Bench to Bedside Case Study. National Academies of Sciences, Engineering, Medicine. Health and Medicine Division. Presentation to: Committee on Issues in Organ Donor Intervention Research. Washington DC, December 14.

International1986 Visiting Professor. Sixth Sapporo Cancer Seminar Visiting Lecturer; “EBV-Related B-Cell

Lymphoproliferative Diseases in Immunosuppressed Patients”; Sapporo Cancer Society, Sapporo, Japan.

1994 Visiting Lecturer. Premier Congres D’oncologie Du Patient Transplante. “Lymphome et Transplantation: Epidémiologie”; French Transplantation Society, Corsica, France; May 27.

1995 Visiting Lecturer. The 29th Annual Meeting of the Japanese College of Surgeons Visiting Lecturer; “Controversies in Liver Transplantation”; Japanese College of Surgeons, Tokyo, Japan; June 24.

2001 Invited Speaker. International Liver Transplantation Society/European Liver Transplantation Society Combined Annual Meeting 2001; “ABO Incompatible Liver Transplants: To Do or Not to Do. A Debate”; Berlin, Germany; July 13.

2004 Invited Speaker. Roche Satellite Symposium, XX Annual Congress of the Transplantation Society; “Association of Immunosuppressive Regimens with Post-transplant Lymphoproliferative Disorder, Graft Survival and Patient Survival after Renal Transplantation”; Vienna, Austria; September 6.

36


2005 Invited Speaker. Japan Society for Transplantation, 41st Annual Meeting; “ABO-incompatible Transplants and Accommodation by Upregulation of Protective Genes: a Hypothesis”; Niigata, Japan; October 29.

Invited Speaker. Japan Society for Transplantation, 41st Annual Meeting; Special Lecture; “Post-transplant Lymphoproliferative Diseases: Current Status and When to Transplant”; Niigata, Japan; October 30.

Invited Speaker. Kobe University Lecture; “Current Status: ABO-incompatible Organ Transplantation and Post-transplant Lymphoproliferative Diseases”; Kobe, Japan; October 31.

2006 Invited Speaker. Satellite Symposium on Ethics of Transplantation. World Transplant Congress, XXI Annual Congress of the Transplantation Society; “The Bulletin versus the Billboard: Solicitation for Donors”; Boston, MA; July 25.

Invited Commentator. The Transplantation Society. Key Opinion Leaders Conference. Buenos Aires, Argentina; October 27-29.

2008 Invited Speaker. State-of-the-Art Symposium. Ethical Issues in Donation and Transplantation. XXII International Congress of the Transplantation Society; “Directed and Conditional Donation from Deceased Donors - What is Acceptable?” Sydney, Australia; August 11.

2009 Invited Commentator. The Transplantation Society. Key Opinion Leaders Conference. Jackson Hole, WY; July 16-19.

Team Chair, Classification of PTLD and the Impact of EBV. PTLD Consensus Conference (Genzyme). Seville, Spain; November 12-15.

2012 Chair, Sunrise Symposium. ELPAT: Extremes in Living Donation. 24 th International Congress of The Transplantation Society. Berlin, Germany; July 17.

Invited Speaker. Sunrise Symposium. ELPAT: Extremes in Living Donation. "Solicitation on the World-Wide-Web." 24th International Congress of The Transplantation Society. Berlin, Germany; July 17.

Chair, Concurrent Oral Session. Societal & Ethics: Aspects of Transplantation. 24 th International Congress of The Transplantation Society. Berlin, Germany; July 17.

Professional and education leadership role related to teaching

1987-1989 American Association of Academic Surgery Member, Program Committee Responsible for evaluation and selection of abstracts for the annual meeting.

1994-1996 American Society of Transplant Surgeons Member, Education Committee Studied manpower needs in the United States and the ability of transplant fellows to find employment in their field (Kaufman D, Ascher N, Education Committee of the American Society of Transplant Surgeons: Quo vadis, my transplant fellow? Transplantation 1998;65:269-272).

37


2001-2003 American Association for the Study of Liver DiseasesChair, Clinical Transplantation and All Other Transplantation Review Group for Annual MeetingResponsible for evaluation and selection of abstracts for the clinical transplant sessions of the AALSD annual meeting.

2001-2004 American Association for the Study of Liver DiseasesMember, Experimental Transplantation; Preservation, Ischemia/Reperfusion; Cell Transplantation; Hepatobiliary Abstract Review Committee for Annual MeetingResponsible for evaluation and selection of abstracts for the transplant and hepatobiliary sessions of the AALSD annual meeting.

2004-2006 American Association for the Study of Liver DiseasesMember, Clinical Transplantation and All Other Transplantation Review Group for Annual Meeting Responsible for evaluation and selection of abstracts for the clinical transplant sessions of the AALSD annual meeting.

2004-2007 American Hepato-Pancreato-Biliary AssociationMember, Program CommitteeResponsible for abstract selection for transplant oral and poster sessions, recruitment of commentators on oral papers, and organization of special speaker events for the transplant sessions.

2005 American Association for the Study of Liver Diseases and International Liver Transplant Society Chair, Transplant Course Session Case presentation/panel discussion; “Which patient should receive which graft?”; AASLD Annual Meeting; San Francisco, CA, November 11.

2005-2007 American Association for the Study of Liver DiseasesMember, Scientific Program CommitteeThe program committee was responsible for organizing all aspects of the AASLD Annual Meeting including abstract selection (plenary, oral, and poster sessions), special lectures, post graduate course, etc.

2006-2007 Liver Diseases Research Branch, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health Member, Steering CommitteeClinical Research Workshop “Improving Long-Term Outcomes for Pediatric Liver Transplantation.”

2007 Liver Diseases Research Branch, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bethesda, MD Moderator Session “Long-Term Immunosuppression after Pediatric Liver Transplantation”; Clinical Research Workshop “Improving Long-Term Outcomes for Pediatric Liver Transplantation”; Bethesda, MD; February 12.

2007 American Association for the Study of Liver Diseases. Member, Organizing CommitteeCo-Moderator, Combined Clinical Session

38


Session “Diagnosis and Management of Benign Liver Masses”; DDW Annual Meeting.Washington, DC; May 22.

2007-2008 American Transplant Congress (joint annual meeting of ASTS/AST) Co-Chair, Abstract Review Committee

2008-2011 American Association for the Study of Liver Diseases Annual MeetingChair, Abstract Review Committee “Clinical Liver Transplantation and Liver Surgery: Immunosuppression, Outcomes and Complications.”

2008 Harvard Medical School and Beth Israel Deaconess Medical Center.Co-Director and Course Organizer along with Dr. Michael Curry.“Advanced Course in Liver Diseases.” January 16-18. Harvard Medical School and Beth Israel Deaconess Medical Center.Co-Director and Course Organizer along with Dr. Michael Curry.“Advanced Course in Liver Diseases.” April 16-18.

2009-2010 American Association for the Study of Liver Diseases.Representative on Organizing Committee for International Consensus Conference“Consensus Conference on HCC and Liver Transplantation.” Sponsored by AASLD, ELITA, IHPBA, ILCA, ILTS, and TTS.Zurich, Switzerland, December 1-5, 2010.

2010-2011 American Transplant Congress (joint annual meeting of ASTS/AST)Co-Chair, Abstract Review Committee, Translational Regulatory Issues.

2011-2012 The Transplantation Society (International)Chair, "Societal and Ethics – Aspects of Transplantation"Berlin, Germany, July 16-19, 2012

2012-2013 The Transplantation Society (International)/3rd ELPAT ConferenceMember, Scientific CommitteeRotterdam, The Netherlands, April 20-24, 2013

E. Report of Clinical Activities:

Description of clinical practice

My clinical practice currently includes liver transplantation (adult and pediatric), multiorgan procurement, and nontransplant hepatobiliary surgery.

Patient load and complexity of cases

My primary patient population consists of complex patients with end stage liver disease requiring liver transplantation and patients with benign and malignant diseases of the liver, gallbladder, and biliary tree.

Clinical research contributions

The most significant original contributions include:

39


a. First classification and elucidation of the clinical, immunopathologic, and virologic characteristics, and pathogenesis of the EBV (Epstein Barr Virus)-related post-transplant lymphoproliferative diseases that has influenced approaches to diagnosis and treatment (Ref #3, 4, 5, 6, 7, 9, 14, 26, 31)

b. First description of antibody mediated hyperacute rejection of a liver in man (Ref #23) and confirmed in subsequent cases (#49)

c. First description of the development of an immunoblastic lymphoma of T-cell type in a renal transplant recipient (Ref #35)

d. First description of a technique for laparoscopic drainage of a post-kidney transplant lymphocele (Ref #40)

e. Prospective randomized comparison of ALG vs. OKT3 for induction immunosuppression in kidney transplantation (Ref #53)

f. First development and implementation of a new technique for complete percutaneous venovenous bypass during liver transplantation (Ref #61)

g. First successful development and implementation of a protocol to prevent immunological graft losses in ABO incompatible liver transplants (Ref #56)

h. Improved technique and long-term results of surgical repair of benign bile duct strictures (Ref #77)

i. Description of relative risk of developing PTLD with various immunosuppressive drugs (Ref #86)

j. Demonstration that maintenance immunosuppression with TOR inhibitors is associated with a reduced incidence of de novo malignancies (#96)

k. Demonstration of the feasibility of renal and extrarenal transplantation from donorsafter cardiac death with ICU extubation (Ref #97) and importance of hypotension and cold ischemic time (Ref #110, 130)

l. Analysis of when it is safe to retransplant patients with a history of PTLD (Ref #101)m. Ethical analysis of challenges posed by the solicitation of deceased and living organ donors

(Ref #104)n. Framing disparities in transplantation and the role of social networks (Ref #113, 121) and

other factors affecting access and outcomes (Ref #126, 133, 138, 149)o. Feasibility of transplant HIV+ patients (kidney and liver) as part of multi-center NIH

sponsored trial (Ref #125, 142, 143, 153, 159, 161)

Basic research contributions

The most significant original contributions include:

p. Studies of the mechanisms of cellular recruitment into rejecting allografts and demonstration of the role of cytokines in altering specific and nonspecific recruitment through changes in migration, blood flow, and vascular permeability similar to DTH type reactions (Ref #8, 10, 11, 13, 15)

q. Demonstration of the survival of in vitro generated T cell clones in vivo and ability to reject allografts in T-cell depleted mice (Ref #32)

r. Demonstration of the ability of CD4+ and CD8+ cells to reject skin allografts in scid (severe combined immunodeficiency) mice (Ref #48)

s. Development of a novel model of delayed graft function in swine and the demonstration that low dose inhaled carbon monoxide can reduce the severity and duration of DGF (Ref #123)

t. Demonstration that carbon monoxide enhances early liver regeneration in mice after hepatectomy (Ref #129)

u. Demonstration that the failure of fibrotic liver regeneration in mice is linked to a severe fibrotic response driven by hepatic hepatic progenitor cell activation (Ref # 151)

40


PART III: Bibliography

h-index 40 from Web of Science (6,595 citations)

Original Articles:

1. Witte MH, Hanto DW, Witte CL. Clinical and experimental techniques to study the lymphatic system. Vascular Surg 1977; 11:120-129.

2. Tack KJ, Peterson PK, Rasp FL, O'Leary M, Hanto DW, Simmons RL, Sabath LD. Isolation of Chlamydia trachomatis from the lower respiratory tract of adults. Lancet 1980; 1:116-120.

3. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Purtilo DT, Klein G, Simmons RL, Najarian JS. The Epstein-Barr virus (EBV) in the pathogenesis of post-transplant lymphoma. Transplant Proc 1981; 13:756-760.

4. Hanto DW, Sakamoto K, Purtilo DT, Simmons RL, Najarian JS. The Epstein-Barr virus in the pathogenesis of post-transplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery 1981; 90:204-213.

5. Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS. A clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of the Epstein-Barr virus. Cancer Research 1981; 41:4253-4261.

6. Frizzera G. Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Sibley RK, Lindquist LL, Holahan KP. Polymorphic diffuse B-cell hyperplasia and lymphomas in renal transplant recipients. Cancer Research 1981; 41:4262-4279.

7. Saemundsen AK, Purtilo DT, Sakamoto K, Sullivan JL, Synnerholm A, Hanto DW, Simmons RL, Anvret M, Collins R, Klein G. Documentation of Epstein-Barr virus (EBV) infection in immune deficient patients with life-threatening lymphoproliferative disease by EBV cRNA/DNA and vDNA/DNA hybridization. Cancer Research 1981; 41:4237-4242.

8. Hanto DW, Hoffman R, Simmons RL. The recruitment of unsensitized circulating lymphocytes to sites of allogeneic cellular interactions. Transplantation 1982; 33:541-546.

9. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Sakamoto K, Purtilo DT, Balfour HH Jr, Simmons RL, Najarian JS. Epstein-Barr virus induced B-cell lymphoma after renal transplantation. Acyclovir therapy and transition from a polyclonal to monoclonal B-cell proliferation. N Engl J Med 1982; 306:913-918.

10. Hanto DW, Hopt UT, Hoffman R, Simmons RL. Lymphocyte recruitment, regional blood flow, and vascular permeability at sites of allogeneic cellular interactions. J Immunol 1982; 129:2437-2443.

11. Hoffman RA, Ascher NL, Hanto DW, Simmons RL. The migration of activated murine T lymphocytes in vitro. II. Evidence for differential locomotion of T cell subsets. J Immunol 1983; 130:1610-1615.

12. Hanto DW, Hopt UT, Hoffman R, Simmons RL. A “lymphokine” mediated increase in lymphocyte recruitment, regional blood flow, and vascular permeability in sponge matrix allografts. Transplant Proc 1983; 15:411-413.

13. Hanto DW, Harty JT, Hoffman RA, Simmons RL. Cyclosporine suppression of lymphocyte

41


recruitment, blood flow, and vascular permeability at sites of allogeneic cellular interactions. Surgery 1983; 94:218-224.

14. Hanto DW, Gajl-Peczalska KJ, Frizzera G, Arthur D, Balfour HH Jr, McClain K, Simmons RL, Najarian JS. Epstein Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann Surg 1983; 198:356-369.

15. Hanto DW, Harty JT, Simmons RL. Lymphocyte recruitment properties of regional lymph node and spleen cells using skin allograft rejection. Transplantation 1983; 36:578-580.

16. Tubman DE, Frick MP, Hanto DW. Lymphoma after organ transplantation: radiologic manifestations in the central nervous system, thorax, and abdomen. Radiology 1983; 149:625-631.

17. Frick MP, Salomonowitz E, Hanto DW, Gedgaudas-McClees K. Computed tomography of abdominal post-transplant lymphomas. Am J Roentgenology 1984; 142:97-99.

18. Hanto DW, Simmons RL, Najarian JS. Epstein-Barr virus induced lymphoproliferative diseases in renal allograft recipients. Heart Transplantation 1984; 3:121-131.

19. Hanto DW, Harty JT, Hoffman RA, Simmons RL. Soluble mediators generated by allogeneic stimulation increase lymphocyte recruitment (LR), regional blood flow (RBF), and vascular permeability (VP) in vitro. Transplant Proc 1985; 17:578-581.

20. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Balfour HH Jr, Simmons RL, Najarian JS. Acyclovir therapy of Epstein Barr virus (EBV)- induced post-transplant lymphoproliferative diseases. Transplant Proc 1985; 17:89-92.

21. Hanto DW, Widmer MB, Simmons RL. Mediation of cellular recruitment in vivo by functionally distinct T cell clones. Transplantation 1986; 42:168-171.

22. Hanto DW, Harty JT, Hoffman RA, Simmons RL. Evidence that secondary mixed leukocyte culture supernatant mediates changes in cellular recruitment, blood flow, and vascular permeability. Transplantation 1986; 42:621-627.

23. Hanto DW, Snover DC, Noreen HJ, Sibley RK, Gajl-Peczalska KJ, Najarian JS, Ascher NL. Hyperacute rejection of a human orthotopic liver allograft in a presensitized recipient. Clin Transplant 1987; 1:304-310.

24. Duffy B, Tyler J, Anderson CB, Hanto DW, Flye MW, Rodey G. The effect of donor-specific blood transfusion on in vitro alloreactive precursor cell frequencies. Transplant Proc 1987; 19:753-754.

25. Bucy RP, Hanto DW, Berens ES, Schreiber RD. Lack of an obligate role for IFN-α in the primary in vitro mixed lymphocyte response. J Immunol 1988; 140:1148-1152.

26. Billiar TR, Hanto DW, Simmons RL. Inclusion of uncomplicated infectious mononucleosis in the spectrum of Epstein-Barr virus infections in transplant recipients. Transplantation 1988; 46:159-161.

27. Farrar RP, Hanto DW, Flye MW, Chaplin H. Blood component use in orthotopic liver transplantation. Transfusion 1988; 28:474-478.

28. Brunt EM, Kissane JM, Cole BR, Hanto DW. Transmission and resolution of membranoproliferative glomerulonephritis, type I in recipients of cadaveric renal allografts. Transplantation 1988; 46:595-598.

29. Andreone PA, Ascher NL, Hanto DW, Najarian JS, Simmons RL. Successful management of wound mucomycosis in a combined hepatic and renal transplant recipient: A case report and

42


literature review. Clin Transplant 1988; 2:119-123.

30. Anderson CB, Jendrisak M, Flye MW, Hanto DW, Anderman CK, Rodey GE, Sicard GA. Renal allograft recipient immunomodulation by concomitant immunosuppression and donor-specific transfusions. Transplant Proc 1988; 20:1074-1078.

31. Hanto DW, Birkenbach M, Frizzera G, Gajl-Peczalska KJ, Simmons RL, Schubach WH. Confirmation of the heterogeneity of post-transplant Epstein-Barr virus - associated B-cell proliferations by immunoglobulin gene rearrangement analyses. Transplantation 1989; 47:458-464.

32. Berens ES, Shelton MW, Walp LA, Basler JT, Hanto DW. Survival of cytotoxic T-cell clones (Tc) in vivo and their ability to effect skin allograft rejection in T-cell depleted mice. Transplant Proc 1989; 21:138-139.

33. Phelan D, Flye MW, Hanto DW, Anderson CB, Mohanakumar T. Positive B cell crossmatches: Specificity of antibody and graft outcome. Transplant Proc 1989; 21:687-688.

34. Anderson CB, Jendrisak MD, Flye MW, Hanto DW, Anderman CK, Rodey GE, Sicard GA. Concomitant immunosuppression and donor-specific transfusions prior to renal transplantation. Transplant Proc 1989; 21:1828-1831.

35. Griffith RC, Saha BK, Janney CM, Ratner L, Brunt EM, Gajl-Peczalska KJ, Hanto DW. Immunoblastic lymphoma of T-cell type in a chronically immunosuppressed renal transplant recipient. Am J Clin Pathol 1990; 93:280-285.

36. Ockner SA, Brunt EM, Cohn SM, Krul ES, Hanto DW, Peters MG. Fulminant hepatic failure due to acute fatty liver of pregnancy treated by orthotopic liver transplantation. Hepatology 1990; 11:59-64.

37. Marsano L, Perrillo RP, Flye MW, Hanto DW, Spitzer ED, Thomas JR, Murray PR, Windus DW, Brunt EM, Storch GA. Comparison of culture and serology for the diagnosis of cytomegalovirus infection in kidney and liver transplant recipients. J Infect Dis 1990; 161:454-461.

38. Ratner LE, Clayman V, Hanto DW. Obstructive uropathy due to ureteral candidiasis in a renal allograft. Clin Transplant 1990; 4:202-205.

39. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Boyle P, Falqui L, Marchetti P, Ricordi C, Gingerich RL, Jaffe AS, Cryer PE, Hanto DW, Anderson CB, Flye MW. Results of our first nine intraportal islet allografts in type 1, insulin dependent diabetic patients. Transplantation 1991; 51:76-85.

40. McCullough CS, Soper NJ, Clayman RV, So SKS, Jendrisak MD, Hanto DW. Laparoscopic drainage of a post-transplant lymphocele. Transplantation 1991; 51:725-741.

41. Goss JA, Cole BR, Jendrisak MD, McCullough CS, So SKS, Windus DW, Hanto DW. Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis: A single center experience and a review of the literature. Transplantation 1991; 52:805-810.

42. Stevens SD, Heiken JP, Brunt E, Hanto DW, Flye MW. Low-attenuation periportal collar in transplanted liver is not reliable CT evidence of acute allograft rejection. Am J Roentgenol 1991; 157:1195-1198.

43. Phelan DL, Hibbett S, Wetter L, Hanto DW, Mohanakumar T. Recombinant erythropoietin: Does it really affect sensitization? Transplant Proc 1991; 23:409-410.

44. Jendrisak MD, Phelan D, Marsh JW, McCullough C, So SKS, Mohanakumar T, Rush, T, Michalski S, Hanto DW. Significance of B cell crossmatch on outcome in renal transplantation. Transplant Proc 1991; 23:434-436.

43


45. Hanto DW, Jendrisak MD, McCullough CS, So SKS, Marsh JW, Rush T, Michalski S, Phelan D, Mohanakumar T. A prospective randomized comparison of prophylactic ALG and OKT3 in cadaver kidney allograft recipients. Transplant Proc 1991; 23:1050-1051.

46. Awad J, Peters MG, Brunt E, Hanto DW. Herpes viral hepatitis in liver transplant recipients. Clin Transplant 1992; 6:16-20.

47. Brunt EM, Peters MG, Flye MW, Hanto DW. Day five protocol liver allograft biopsies document early rejection episodes and are predictive of recurrent rejection. Surgery 1992; 111:511-517.

48. Shelton MW, Walp L, Basler JT, Uchiyama K, Hanto DW. CD4+ and CD8+ T cells mediate skin allograft rejection in scid mice. Transplantation 1993; 54:278-286.

49. Ratner LE, Phelan D, Brunt EM, Mohannakumar T, Hanto DW. Probable antibody-mediated failure of two sequential ABO compatible hepatic allografts in a single recipient. Transplantation 1993; 55:814-819.

50. Hanto DW, Brunt EM, Goss JA, Cole BR. Accelerated acute rejection of an A2 renal allograft in an O recipient. Association with an increase in anti-A2 antibodies. Transplantation 1993; 56:1580-1583. PMID: 8305085

51. Bailey TC, Powderly WG, Storch GA, Dunkel JD, Woodward RS, Spitznagel E, Hanto DW, Dunagan WC. Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota Anti-lymphoblast Globulin (MALG) or OKT3 for rejection prophylaxis. Am J Kid Dis 1993; 21:196-201.

52. Bailey TC, Ettinger NA, Storch GA, Trulock EP, Hanto DW, Dunagan WC, Jendrisak MD, McCullough CS, Kenzora JL, Powderly WG. Failure of high dose oral acyclovir with or without immune globulin, to prevent primary CMV disease in solid organ transplant recipients. Am J Med 1993; 95:273-278. PMID: 8396320

53. Hanto DW, Jendrisak MD, So SKS, McCullough CS, Rush TM, Michalski SM, Phelan D, Mohanakumar T. Induction immunosuppression with ALG or OKT3 in cadaver kidney transplantation: results of a single institution prospective randomized trial. Transplantation 1994; 57:377-384.

54. Schroeder TJ, Michael AT, First MR, Hariharan S, Bhat G, Hanto DW, Ryckman FC, Balistreri WF. Variations in serum OKT3 concentration based upon age, sex, organ transplanted, treatment regimen, and anti-OKT3 antibody status. Ther Drug Monit 1994; 16:361-367.

55. Rossi SJ, Schroeder TJ, Muth KL, Hanto DW, Balistreri WF, Ryckman FC. Soluble interleukin-2 receptor monitoring during bacterial and viral infections in liver transplant recipients: a comparative evaluation. Clin Transplantation 1994; 8:479-484.

56. Hanto DW, Ruger JK, Rossi SJ: Alloresponses in vitro and in vivo show restricted T cell receptor (TCR) V gene usage. Transplant Proc 1995; 27:491-493.

57. Valente JF, Alonso MH, Weber FL, Hanto DW. Late hepatic artery thrombosis (HAT) in liver allograft recipients is associated with intrahepatic biliary necrosis. Transplantation 1996; 61:61-65.

58. Reif MC, Hanto DW, Moulton JS, Alspaugh JP, Bejarano P. Primary hepatic pheochromocytoma? Am J Hypertension 1996; 9:1040-1043. PMID:8896659

59. Mira JL, Hanto DW. Primary malignant melanoma of the common bile duct. J Surg Pathol 1996; 2:99-103.

60. Rossi S, Schroeder T, Muth K, Hanto D, Munda R, Hariharan S, First MR, Ryckman F, Balistreri W. Serial monitoring of soluble interleukin-2 receptor as a rapid marker of

44


cytomegalovirus infection and response to antiviral therapy. Clin Transplant 1996; 10:45-50.

61. Johnson SR, Marterre WF, Alonso MH, Hanto DW. A percutaneous technique for venovenous bypass in orthotopic cadaver liver transplantation (OLTx) and comparison with the standard open technique. Liver Transpl Surg 1996; 2:354-361.

62. Ray MB, Schroeder T, Michaels SE, Hanto DW. Increased expression of proliferating cell nuclear antigen in liver allograft rejection. Liver Transplantation and Surgery 1996; 2:337-342.

63. Kemper RR, Menitove J, Hanto DW. Cost analysis of intraoperative blood salvage during orthotopic liver transplantation. Liver Transpl Surg 1997; 3:513-517.

64. Schulak JA, Ferguson RM, Hanto DW, Ryckman FC, Vogt DP, Bohnengel A. Liver transplantation in Ohio. Surgery 1997; 122: 842-849.

65. Kaufman D, Ascher N, Education Committee of the American Society of Transplant Surgeons: Quo vadis, my transplant fellow. Transplantation 1998; 65:269-272.

66. Whiting JF, Rossi S, Hanto DW. Infectious complications following OKT3 induction therapy in liver transplantation. Liver Transpl Surg 1997; 3:563-570.

67. Whiting JF, Fecteau AF, Martin J, Bejarano PA, Hanto DW. Use of low dose OKT3 as induction therapy in liver transplantation. Transplantation 1998; 65:577-580.

68. Bejarano PA, Blanco R, Hanto DW. Solitary fibrous tumor of the liver: A case report, review of the literature, and differential diagnosis of spindle cell lesions of the liver. Int J Surg Pathol 1998; 6:93-100.

69. Fecteau AH, Penn I, Hanto DW. Peritoneal metastasis of intracranial glioblastoma via a ventriculoperitoneal shunt preventing organ retrieval: Case report and review of the literature. Clin Transplant 1998; 12:348-350.

70. Thielke J, Martin J, Weber FL, Schroeder TJ, Goretsky S, Hanto DW. Pharmacokinetics of tacrolimus and cyclosporine (Sandimmune and Neoral) in a patient with short bowel syndrome. Liver Transpl Surg 1998; 4:432-434.

71. Martin J, Fleck P, Schroeder J, Whiting J, Hanto D. The cost of rejection in liver allograft recipient. Transplant Proc 1998; 31:1500-1501.

72. Sherman KE, Sickler J, Aranda-Michel J, Weber FL, Martin S, Whiting J, Hanto DW. Rimantadine for treatment of hepatitis C infection in liver transplant recipients. Liver Transpl Surg 1999; 5:25-28.

73. Whiting JF, Martin J, Zavala E, Hanto DW. The influence of clinical variables on hospital costs following orthotopic liver transplantation. Surgery 1999; 125:217-222.

74. Jin SY, Noffsinger AE, Bejarano P, Weber FL, Hanto DW, Belli JM, Fenoglio-Preiser CM. Microsatellite instability in primary sclerosing cholangitis. Dig Dis Sci 1999; 44:595-601.

75. Whiting JF, Nabel J, Grossman P, Martin JE, Hanto DW, First MR. Clinical determinants of health related quality of life (HRQL) in solid organ transplant recipients. J Surg Outcomes 1999; 2:21-26.

76. Tiao GM, Martin J, Weber FL, Cohen RM, Hanto DW. Case report: Addisonian crisis in a liver transplant patient due to fluconazole withdrawal. Clin Transplant 1999; 13:62-64.

77. Johnson SR, Pennington LJ, Hanto DW. Long term results of surgical repair of bile duct injuries following laparoscopic cholecystectomy. Surgery 2000; 128:668-677.

78. Johnson SR, Kelly BS, Pennington LJ, Hanto DW. A single center experience with extrahepatic cholangiocarcinomas. Surgery 2001; 130:584-592.

45


79. Phillips AL, Walker EL, Martin JE, First MR, Hanto DW, Whiting JF. Quality of life as a predictor of morbidity, mortality, and resource utilization after solid-organ transplant. Transplant Proc 2001; 33:1886.

80. Feng S, Buell JF, Cherikh WS, Deng MC, Hanto DW, Kauffman HM, Leichtman AB, Lorber MI, Maters RG, McBride MA, Metzger RA, Nolte FS, O’Connor KJ, Roth D, Terrault NA, Henry ML. Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation. Transplantation 2002; 74:1657-1663.

81. Akoad M, Giraldo M, Monaco AP, Hanto DW, Uknis ME. Enteric drainage of a pancreas allograft is safe for patients with celiac sprue. Clin Transplant 2002; 16:387-388.

82. Hanto DW, Fecteau AH, Alonso MH, Valente JF, Whiting JF. ABO incompatible liver transplantation with no immunological graft losses utilizing total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl 2003; 9:22-30.

83. Hanto DW. Reliability of voluntary and compulsory databases and registries in the United States. Transplantation 2003; 75:2162-2164.

84. Kim J, Ahmad SA, Lowy AM, Buell JF, Pennington LJ, James LE, Matthews JB, Hanto DW. Increased biliary fistulas following liver resection with the harmonic scalpel. Am Surg 2003; 69:815-819.

85. Guiney MJ, Kruskal JB, Sosna J, Hanto DW, Goldberg SN, Raptopoulos V. Multi-detector row CT of relevant vascular anatomy of the surgical plane in split liver resection. Radiology 2003; 229:401-407.

86. Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto, DW. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. (Rapid Communications) Transplantation 2003; 76:1289-1293.

87. Hanto DW. Clinical Crossroads: A 51-year-old man with hepatitis-C cirrhosis needing liver transplantation. JAMA 2003; 290:3238-3246.

88. Feng S, Buell JF, Chari RS, DiMaio M, Hanto DW. Tumors and Transplantation: The 2003 Third Annual ASTS State-of-the-Art Winter Symposium. Am J Transplant 2003; 3:1481-1487.

89. Kim J, Ahmad S, Lowy AM, Matthews J, Buell J, Pennington LJ, Moulton J, Hanto DW. An algorithm for the accurate identification of benign liver lesions. Am J Surg 2004; 187:274-279.

90. Brown RS, Rush SH, Rosen HR, Langnas AN, Klintmalm GB, Hanto DW, Punch JD. SRTR report on the state of transplantation. Liver and intestine transplantation. Am J Transplant 2004; 4:81-92.

91. Paranjape C, Johnson SR, Khwaja K, Goldman H, Kruskal J, Hanto DW. Clinical characteristics, treatment, and outcome of pancreatic schwannomas. J of Gastrointestinal Surg 2004; 8:706-712.

92. Byrnes V, Cardenas A, Afdhal N, Hanto D. Symptomatic focal nodular hyperplasia during pregnancy: a case report. Annals of Hepatology 2004; 3:35-37.

93. Hanto DW, Fishbein TM, Pinson CW, Olthoff KM, Shiffman ML, Punch JD, Goodrich NP. Liver and intestine transplantation: summary analysis, 1994-2003. Am J Transplant 2005; 5:916-933.

94. Wray CJ, Lowy AM, Matthews JB, Park S, Choe KA, Hanto DW, James LE, Soldano DA, Ahmad SA. The significance and clinical factors associated with a sub-centimeter resection of colorectal metastases. Annals Surg Oncol 2005; 12(5):374-380.

46


95. Johnson SR, Khwaja K, Pavlakis M, Monaco AP, Hanto DW. Older living donors provide excellent quality kidneys: a single center experience. Clin Transplant 2005; 19:600-606.

96. Kauffman HM, Cherikh WS, Cheng Y, Hanto DW, Kahan BD. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 2005; 80:883-889.

97. Johnson SR, Pavlakis M, Khwaja K, Karp S, Curry M, Curran CC, Monaco A, Hanto DW. Intensive care unit extubation does not preclude extrarenal organ recovery from donors after cardiac death. Transplantation 2005; 80:1244-1250.

98. Lerner AB, Sundar E, Mahmood F, Sarge T, Hanto DW, Panzica PJ. Four cases of cardiopulmonary thromboembolism during liver transplant without the use of antifibrinolytic drugs. Anesth Analg 2005; 101:1608-1612.

99. Lima MA, Hanto DW, Curry MP, Wong MT, Dang X, Koralnik IJ. Atypical radiological presentation of progressive multifocal leukoencephalopathy following liver transplantation. J NeuroVirology 2005; 11:46-50.

100. Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW, Callery M, Arky R, Nose V, Bonner-Weir S, Goldfine AB. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 2005; 48:2236-2240. Epub 2005 Sep 30. www.diabetologia-journal.org.

101. Johnson SR, Cherikh WS, Kauffman HM, Pavlakis M, Hanto DW. Retransplantation after lymphoproliferative disorders: an OPTN/UNOS database analysis. Am J Transplant 2006; 6:2743-2749.

102. Englesbe MJ, Dimick J, Mathur A, Welling TH, Pelletier SJ, Heidt DG, Magee JC, Sung RS, Punch JD, Hanto DW, Campbell DA, Jr. Who pays for biliary complications following liver transplant? A business case for quality improvement. Am J Transplant 2006; 6:2978-2982.

103. Hanto DW. ABO incompatible transplantation. Accommodation by upregulation of protective genes: a hypothesis. International Congress Series July 2006; 1292;53-60.

104. Hanto DW. Ethical challenges posed by the solicitation of deceased and living organ donors. N Engl J Med 2007; 356:1062-1066.

105. Johnson SR, Alexopolous S, Curry M, Hanto DW. Primary nonfunction (PNF) in the MELD era: an SRTR database analysis. Am J Transplant 2007; 7:1003-1009.

106. Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW. Deceased donors with a past history of malignancy: an OPTN/UNOS update. Transplantation 2007; 84:272-274.

107. Wray CJ, Lowy AM, Matthews JB, James LE, Choe KA, Hanto DW, Ahmad SA. Intraoperative margin re-resection for colorectal metastases. J Surg Ed 2007; 64:150-157.

108. Rodrigue JR, Pavlakis M, Danovitch GM, Johnson SR, Karp SJ, Khwaja K, Hanto DW, Mandelbrot DA. Evaluating living kidney donors: relationship types, psychosocial criteria, and consent processes at transplant programs in the United States. Am J Transplant 2007; 7:2326-2332.

109. Mandelbrot DA, Pavlakis M, Danovitch GM, Johnson SR, Karp SJ, Khwaja K, Hanto DW, Rodrigue JR. The medical evaluation of living kidney donors: a survey of US transplant centers. Am J Transplant 2007; 7:2333-2343.

110. Ho K, Owens C, Johnson S, Khwaja K, Curry M, Pavlakis M, Mandelbrot D, Pomposelli J, Shah S, Saudi R, Kop D, Male S, Belcher J, Hull D, Tullius S, Freeman R, Pomfret E, Whiting J, Hanto D, Karp, S. Donor post-extubation hypotension and age correlate with outcome after

47

http://www.diabetologia-journal.org/

http://www.diabetologia-journal.org/


donation after cardiac death transplantation. Transplantation 2008; 85:1588-1594.

111. Rodrigue JR, Antonellis T, Mandelbrot D, Hanto DW. Web-based requests for living organ donors: Who are the solicitors? Clin Transplantation 2008; 22:749-753.

112. Bucuvalas JC, Alonso E, Magee J, Talwalkar J, Hanto DW, Doo E. Improving long-term outcomes after liver transplantation in children. Am J Transplant 2008; 8:2506-2513.

113. Ladin K, Rodrigue JR, Hanto DW. Framing disparities along the continuum of care from chronic kidney disease to transplantation: barriers and interventions. Am J Transplant 2009; 9:669-674. PMID: 19344460

114. Reich DJ, Mulligan DC, Abt PL, Pruett TL, Abecassis MM, D’Alessandro A, Pomfret EA, Freeman RB, Markmann JF, Hanto DW, Matas AJ, Roberts JP, Merion RM, Klintmalm GB, ASTS Standards on Organ Transplantation Committee. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant 2009; 9:2004-2011. Epub 2009 July 16.

115. Egbuna O, Davis RB, Chudzinski R, Pavlakis M, Rogers C, Molakatalla P, Johnson SR, Karp S, Monaco AP, Tang H, Hanto DW, Mandelbrot DA. Outcomes with conversion from calcineurin inhibitors to sirolimus after renal transplantation in the context of steroid withdrawal or steroid continuation. Transplantation 2009; 88:684-692. PMID: 19741466

116. Rogers CC, Johnson SR, Mandelbrot DA, Pavlakis M, Horwedel T, Karp SJ, Egbuna O, Rodrigue JR, Chudzinski RE, Goldfarb-Rumantzev AS, Hanto DW, Curry MP. Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients. Clin Transplant 2009; 23:887-896. Epub 2009 July 28. PMID: 19681971

117. Mandelbrot DA, Pavlakis M, Johnson SR, Karp SJ, Hanto DW, Rodrigue JR. Practices and barriers in long-term living kidney donor follow-up: a survey of US transplant centers. Transplantation 2009; 88:855-860. PMID: 19935453

118. Kakoza RM, Vollmer CM Jr, Stuart KE, Takoudes T, Hanto DW. Pancreatic adenocarcinoma in the pregnant patient: a case report and literature review. J Gastrointest Surg 2009; 13:535-541. Epub 2008 Sept 25.

119. Dib MJ, Ho KJ, Hanto DW, Karp SJ, Johnson SR. Roux limb volvulus after pancreas transplantation: an unusual cause of pancreatic graft loss. Clin Transplantation 2009; 23:807-811. Epub 2009 Jan 10.

120. Chudzinski RE, Khwaja K, Teune P, Miller J, Tang H, Pavlakis M, Rogers C, Johnson S, Karp S, Hanto D, Mandelbrot D. Successful DCD kidney transplantation using early corticosteroid withdrawal. Am J Transplant 2010; 10:115-123. Epub 2009 Dec 2. PMID 19958332

121. Ladin K, Hanto DW. Understanding disparities in transplantation: Do social networks provide the missing clue? Am J Transplant 2010; 10:472-476. Epub 2010 Jan 5. PMID: 20055801

122. Rodrigue JR, Nelson DR, Reed AI, Hanto DW, Curry M. Fatigue and sleep quality before and after liver transplantation. Prog in Transplant 2010;20: 221-233. PMID: 20929106

123. Hanto DW, Maki T, Csizmadia E, Yoon MH, Konduru B, Smith RN, Thomas M, Wegiel B, Otterbein LE. Intraoperative administration of inhaled carbon monoxide reduces delayed graft function in kidney allografts in swine. Am J Transplant 2010;10: 2421-2430. PMID: 20977633

124. Croome KP, Chudzinski R, Hanto DW. Increasing time delay from presentation until surgical referral for hepatobiliary (HB) malignancies. HPB (Oxford) 2010;12: 644-648. Epub 2010 Oct 20. PMID: 20961373

125. Stock PG, Barin B, Murphy B, Hanto DW, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A, Harland R, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Kumar A,

48


Stosor V, Stablein DM, Roland ME. Kidney transplant outcomes in one hundred and fifty HIV-infected recipients. N Engl J Med 2010;363:2004-2014. Erratum in : N Engl J Med 2011; 364:1082. PMID: 21083386

126. Sandhu GS, Khattak M, Woodward R, Hanto DW, Dimitri N, Goldfarb-Rumyantzev A. Impact of substance abuse on access to renal transplantation. Transplantation 2011;91:86-93. Epub 2010 Oct 20. PMID: 20966832

127. Rodrigue JR, Mandelbrot DA, Hanto DW, Johnson SR, Karp SJ, Pavlakis M. A cross-sectional study of fatigue and sleep quality before and after kidney transplantation. Clin Transplant 2011; 25:E13-21. Epub 2010 Oct 21. PMID: 20961334

128. Rodrigue JR, Dimitri N, Reed A, Antonellis T, Hanto DW, Curry M. Quality of life and psychosocial functioning of spouse/partner caregivers before and after liver transplantation. Clin Transplant 2011; 25: 239-247. Epub 2010 Feb 4. PMID: 20184628

129. Kuramitsu K, Csizmadia E, Gallo, D, Hanto DW*, Otterbein LE*. Carbon monoxide enhances early liver regeneration in mice after hepatectomy. Hepatology 2011;53:2016-2026. Epub 2011 Mar 23. PMID:21433045. *These authors contributed equally to this study.

130. Karp SJ, Johnson S, Evenson A, Curry MP, Manning D, Malik R, Lake-Bakaar G, Lai M, Hanto D. Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation. HPB (Oxford) 2011; 13:411-416. Epub 2011 Apr 4. PMID: 21609374

131. Rodrigue JR, Hanto DW, Curry MP. Patients’ expectations and success criteria for liver transplantation. Liver Transpl 2011; 17:1309-1317. Epub 2011 Jun 7. PMID: 21656656

132. Rodrigue JR, Hanto DW, Curry MP. Patients’ willingness to accept expanded criteria donor liver transplantation. Am J Transplant 2011; 11:1705-1711. Epub 2011 June 14. PMID: 21672150.

133. Goldfarb-Rumyantzev AS, Sandhu GS, Khattak M, Barenbaum A, Hanto DW. Social adaptability index predicts access to kidney transplantation. Clin Transplant 2011; 25:834-842. Epub 2011 Jan 27. PMID: 21269329

134. Ladin K, Hanto DW. Rational rationing or discrimination: balancing equity and efficiency considerations in kidney allocation. Am J Transplant 2011; 11:2317-2321. Epub 2011 Sept 11. PMID: 21906253.

135. Rodrigue JR, Nelson DR, Reed AI, Hanto DW, Curry M. Is Model for End-Stage Liver Disease score associated with quality of life after liver transplantation? Prog in Transplant 2011; 21:207-214. PMID: 21977881.

136. Hanto DW, Kane RA, Raven K. Acute rise in creatinine in a long-term kidney transplant recipient. Images in Transplantation. Am J Transplant 2011; 11:2772; quiz 2773. PMID: 22123281.

137. Pavlakis M, Hanto DW. Clinical pathways in transplantation: a review and examples from Beth Israel Deaconess Medical Center. Clin Transplant 2012; 26:382-386. Epub 2011 Dec 5. PMID: 22136467.

138. Garg J, Karim M, Tang H, Gurprataap SS, DeSilva R, Rodrigue J, Pavlakis M, Hanto DW, Goldfarb-Rumyantzev AS. Social adaptability index predicts kidney transplant outcomes; a single-center retrospective analysis. Nephrol Dial Transplant 2012; 27:1239-1245. Epub 2011 Oct 29. PMID: 22036942.

139. Francis JM, Palmer MR, Donohoe K, Curry M, Johnson SR, Karp SJ, Evenson AR, Pavlakis M, Hanto DW, Mandelbrot D. Evaluation of native kidney recovery after simultaneous liver-kidney transplantation. Transplantation 2012:93:530-535. PMID:22245875.

49


140. Pruett TL, Blumberg EA, Cohen DJ, Crippin JS, Freeman RB, Hanto DW, Mulligan DC, Green MD. A consolidated biovigilance system for blood, tissue, organs: One size does not fit all. Am J Transplant 2012;12:1099-1101. Epub 2012 Apr 9. PMID: 22487495.

141. Johnson S, Karp S, Curry M, Barugel M, Rodrigue JR, Mandelbrot DA, Rogers C, Hanto DW. Liver transplant center risk tolerance. Clin Transplant 2012;26: E269-E276. PMID: 22686950.

142. Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, Ragni MV, Barin B, Simon D, Olthoff KM, Johnson L, Stosor V, Jayaweera D, Fung J, Sherman KE, Subramanian, Millis JM, Slakey D, Berg CL, Carlson L, Ferrell L, Stablein DM, Odim J, Fox L, Stock PG for the Solid Organ Transplantation in HIV: Multi-Site Study Investigators. Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study. Liver Transplant 2012;18: 716-726. Epub 2012 May 29. PMID: 22328294.

143. Harbell J, Fung J, Nissen N, Olthoff K, Florman SS, Hanto DW, Light J, Bartlett ST, Tzakis AG, Pearson TC, Barin B, Roland ME, Stock PG; HIV-TR Investigators. Surgical complications in 275 human immunodeficiency virus (HIV) infected liver and/or kidney transplant recipients. Surgery 2012;152:376-381. PMID: 22938898

144. Hanto DW, Curry MP, Sun M, Nasser I. Hepatocellular carcinoma (HCC) in a patient with hepatitis B virus (HBV) infection. Am J Transplant 2012; 12:786-787;quiz 788. PMID: 22372460.

145. Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier; OLT for HCC Consensus Group. Recommendations for liver transplantation for hepatocellular carcinoma: an international conference report. Lancet Oncol 2012;13:e11-22. Epub 2011 Oct 31. PMID: 22047762.

146. Zinser MJ, Hanto DW. Liver transplantation in a patient with developmental interruption of the inferior vena cava with azygos substitution. Transplant Proc 2012;44: 1460-1463. PMID 22664037

147. Hshieh TT, Sundaram V, Najarian RM, Hanto DW, Karp SJ, Curry MP. Hepatitis B surface antigen as a marker for recurrent, metastatic hepatocellular carcinoma after liver transplantation. Liver Transpl 2012; 18: 995-998. PMID 228294

148. Glotz D, Chapman JR, Dharnidharka VR, Hanto DW, Castro MC, Hirsch HH, Leblond V, Mehta AK, Moulin B, Pagliuca A, Pascual J, Rickinson AB, Russo FP, Trappe RU, Webster AC, Zuckerman AO, Gross TG. The Seville expert workshop for progress in posttransplant lymphoproliferative disorders. Transplantation 2012; 94(8):784-793. PMID: 22992767

149. Sandhu GS, Khattak M, Pavlakis M, Woodward R, Hanto DW, Wasilewski MA, Dimitri N, Goldfarb-Rumyantzev A. Recipient’s unemployment restricts access to renal transplantation Clin Transplant 2013;27:598-606. Epub 2013 Jun 30 PMID: 23808849

150. Ladin K, Hanto DW. Rationing Lung Transplants – Procedural Fairness in Allocation and Appeals. N Engl J Med 2013; 369:599-601. Epub 2013 July 24. PMID: 23883330

151. Kuramitsu K, Sverdlov DY, Liu SB, Csizmadia E, Burkly L, Schuppan D, Hanto DW, Otterbein L, Popov Y. Failure of fibrotic liver regeneration in mice is linked to a severe fibrotic response driven by hepatic hepatic progenitor cell activation. Am J Path 2013; 183:182-194. Epub 2013 May 14. PMID: 23680654

152. Beard RE, Hanto DW, Gautam S, Miksad RA. A comparison of surgical outcomes for non-cirrhotic and cirrhotic hepatocellular carcinoma patients in a Western institution. Surgery 2013; 154:545-555. Epub 2013 Jun 15. PMID: 23777589

153. Bahirwani R, Barin B, Olthoff K, Stock P, Murphy B, Reddy KR for the Solid Organ Transplantation in HIV: Multi-Site Study Investigators. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus

50


human immunodeficiency virus-infected recipients without hepatitis C virus: Results from the National Institutes of Health Multi-Site Study. Liver Transplant 2013;19: 619-626. Epub 2013 May 28. PMID: 23512786.

154. Rodrigue JR, Nelson DR, Hanto DW, Reed AI, Curry MP. Patient-reported immunosuppression nonadherence 6 to 24 months after liver transplant: association with pre-transplant psychosocial factors and perceptions of health status change. Prog Transplant 2013; 23:319-328. PMID: 24311395

155. Rodrigue JR, Hanto DW, Curry MP. The alcohol relapse risk assessment: A scoring system to predict the risk of relapse to any alcohol use after liver transplant. Prog Transplant 2013; 23:310-318. PMID: 24311394

156. Rogers CC, Asipenko N, Horwedel T, Gautam S, Goldfarb-Rumyantzev AS, Pavlakis M, Johnson SR, Karp SJ, Evenson A, Hanto DW, Mandelbrot DA. Renal transplantation in the setting of early steroid withdrawal: a comparison of rabbit anti-thymocyte globulin dosing in two eras. Am J Nephrol 2013; 38:397-404. Epub 2013 Oct 26. PMID: 24192457

157. Rodrigue JR, Hanto DW, Curry MP. Substance abuse treatment and its association with relapse to alcohol use following liver transplantation. Liver Transplant 2013; 19:1387-1395. Epub 2013 Oct 1. PMID: 24123780

158. Ujire MP, Curry MP, Stillman IE, Hanto DW, Mandelbrot DA. A simultaneous liver-kidney transplant recipient with IgA nephropathy limited to native kidneys and BK virus nephropathy limited to the transplant kidney. Am J Kidney Dis 2013;62:331-334. Epub 2013 Mar 9. PMID 23477799

159. Terrault N, Reddy KR, Poordad F, Curry M, Schiano T, Johl J, Shaikh O, Dove L, Shetty K, Millis M, Schiff E, Regenstein F, Barnes D, Barin B, Peters M, Roland M, Stock P and for the HIVTR Investigators. Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coninfected liver transplant recipients. Am J Transplant 2014; 14:1129-1135. Epub 2014 Mar 17. PMID: 224636466

160. Hanto DW. Patient safety begins with me. Ann Surg 2014; 260:971-972. Epub 2014 May 12. PMID: 25033225

161. Catana AM, Curry M, Hanto DW. Abdominal mass found in a liver transplant recipient. Am J Transplant 2015;15:2522-2524. PMID: 26288170

162. Roland ME, Barin B, Huprikar S, Murphy B, Hanto DW, Blumberg E, Olthoff K, Simon D, Hardy WD, Beatty G, Stock PG; HIVTR Study Team. Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS 2016;30:435-444. PMID: 26765937

163. Aguero F, Rimola A, Stock P, Grossi P, Rockstroh JK, Agarwal K, Garzoni C, Barcan LA, Maltez F, Manzardo C, Mari M, Ragni MV, Anadol E, Di Benedetto F, Nishida S, Gastaca M, Miro JM; FIPSE/NIH HIVTR/NEAT023 Investigators. Liver retransplantation in patients with HIV-1 infection: an international multicenter cohort study. Am J Transplant 2016;16:679-687. PMID: 26415077

163. Griffith OL, Griffith M, Krysiak K, Magrini V, Ramu A, Skidmore ZL, Kunisaki JH, Austin R, McGrath S, Zhang J, Demeter R, Graves T, Eldred JM, Walker J, Larson DE, Maher CA, Lin Y, Chapman W, Mahadevan A, Miksad R, Nasser I, Hanto DW, Mardis ER. A genomic case study of mixed fibrolamellar carcinoma. Ann Oncol 2016;27:1148-1154. Epub 2016 March 30. PMID: 27029710

164. Ladin K, Zhang G, Hanto DW. Geographic disparities in liver availability: Accidents of geography or consequences of poor social policy? Am J Transplant 2017;17:2277-2284. Epub

51


2017 May 5. PMID: 28390101.

165. Ladin K, Emerson J, Butt Z, Gordon EJ, Hanto DW, Perloff J, Daniels N, Lavelle TA. How important is social support in determining patients’ suitability for transplantation? Results from a national survey of transplant clinicians. J Med Ethics (in press).

166. Ye F, Sheng Q, Feurer I, Zhao Z, Fan R, Teng J, Ping J, Riga SA, Hanto DW, Shyr Y, Karp SJ. Similar regional mortality among patients waiting for a liver transplant: implications and directed solutions to address access inequality. Am J Transplant, Epub 24 April 2018 https://doi.org/10.1111/ajt.14889.

167. Ladin K, Emerson J, Berry K, Butt Z, Gordon EJ, Daniels N, Lavelle TA, Hanto DW. The social support criterion in patient selection: a national survey of transplant providers. (submitted)

Reviews, Chapters, and Editorials:

Reviews and editorials

1. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL, Najarian JS, Balfour HH Jr. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation [letter]. N Eng J Med 1982; 307:896-897.

2. Ascher NL, Hoffman R, Hanto DW, Simmons RL. Cellular events within the rejecting allograft. Transplantation 1983; 35:193-197.

3. Ascher NL, Hoffman RA, Hanto DW, Simmons RL. Cellular basis of allograft rejection. Immunol Rev 1984; 77:217-232.

4. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Simmons RL. Epstein-Barr virus, immunodeficiency and B-cell lymphoproliferation. Transplantation 1985; 39:461-472.

5. Hanto DW. EBV diseases in immunocompromised patients: diagnosis and management. In: Balfour JJ Jr., editor. Advances in Therapy Against Herpes Virus Infections in Immunocompromised Hosts. Minneapolis: University of Minnesota; 1985. p. 41-45.

6. Hanto DW, Najarian JS. Advances in the diagnosis and treatment of EBV-associated lymphoproliferative diseases in immunocompromised hosts. J Surg Oncol 1985; 30:215-220.

7. Hanto DW, Sutherland DER. Pancreas transplantation: Clinical considerations. Radiologic Clinics of North America 1987; 25:333-343.

8. Hanto DW, Simmons RL. Renal transplantation: Clinical considerations. Radiologic Clinics of North America 1987; 25:239-248.

9. Hanto DW, Simmons RL. B-cell lymphoma in a 12-year-old renal transplant patient with fever and lymphadenopathy. In: Simmons RL, editor. Transplant Management. New York: Park Row Publishers; 1987.

10. Ratner LE, Hadley GA, Hanto DW, Mohanakumar T. Immunology of renal allograft rejection. Arch of Path and Lab Med 1991; 115:283-287.

11. Hanto DW. Polyclonal and monoclonal posttransplant lymphoproliferative diseases (LPD). Clin Transplant 1992; 6:227-234.

12. Hanto DW. Classification of Epstein-Barr virus (EBV) associated posttransplant lymphoproliferative diseases (LPD): implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med 1995; 46:381-394.

13. Hanto DW. What’s new in transplantation. J Am Coll Surg 1998; 186:232-239.

52


14. Schulak JA, Bohnengel A, Hanto DW, Henderson JM, Henry ML, Walsh TE, Ryckman FC. The Ohio Solid Organ Transplantation Consortium: a 15-year experience. Transplantation Reviews 1999; 13:135-147.

15. Kauffman HM, McBride MA, Cherikh WS, Spain PC, Hanto DW, Delmonico FL. Donor related malignancies. Transplantation Reviews 2002; 16:177-191.

16. Hanto DW. Reply to letter to the editor written by Daily OP and Kauffman HM. Transplantation 2004; 77:1309-1310.

17. Cherikh WS, Kauffman HM, Swinnen LJ, Hanto, DW. Response: type of induction immunosuppression and posttransplant lymphoproliferative disorder. Transplantation 2004; 78:634.

18. Hanto DW. Association of type of induction with posttransplant lymphoproliferative disorders [letter]. Am J Transplant 2004; 4:1552.

19. Hanto DW. Retransplantation after post-transplant lymphoproliferative diseases (PTLD): When is it safe? Editorial. Am J Transplant 2004; 17:1733-1734.

20. Hanto DW. Family disagreement over organ donation. Commentary. Virtual Mentor 2005; 7(9). At: http://www.ama-assn.org/ama1/pub/upload/mm/384/cc2_0905.pdf.

21. Kauffman HM, Cherikh WS, McBride MA, Cheng YA, Delmonico FL, Hanto DW. Transplant recipients with a history of a malignancy: risk of recurrent and de novo cancers. Transplantation Reviews 2005; 19(1):55-64.

22. Hanto DW. Continued progress in the care of patients with liver failure. Editorial. Curr Opin Organ Transplant 2006; 11:211-212.

23. Karp SJ, Ku Y, Johnson S, Khwaja K, Curry M, Hanto D. Surgical and non-surgical approaches to hepatocellular cancer. Curr Opin Organ Transplant 2006; 11:226-233.

24. Kauffman HM, Cherikh WS, McBride MA, Cheng YA, Hanto DW. Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transplant International 2006; 19:607-620.

25. Hanto DW. Anatomic and technical aspects of hepatic artery reconstruction in living donor liver transplantation. Invited Commentary. Surgery 2006; 140:829.

26. Hanto DW. Autogenous arteriovenous hemodialysis access. Commentary. Fischer JE, editor. Mastery of Surgery. Fifth Edition. Philadelphia: Lippincott, Williams and Wilkins 2007. p. 2263.

27. Pavlakis M, Hanto D, Mandelbrot D. Do we know enough to mandate donor evaluation testing? Letter. Am J Transplant 2008; 8:466.

28. Tibell A, on behalf of the Ethics Committee of the Transplantation Society. The Transplantation Society statement on directed and conditional donation. Transplantation 2008; 85:1538-1539.

29. Hanto DW. Ethics committee oversight of living related donor kidney transplantation in China. Editorial. Am J Transplant 2008; 8:1765-1766.

30. Hanto DW. What does the CONVERT trial data really tell us about conversion from calcineurin inhibitors to sirolimus? Editorial. Transplantation 2009; 87:164-165.

31. Tilney N, Murray J, Thistlethwaite R, Norman D, Delmonico F, Hanto D, Leichtman A, Danovitch G, Sayegh M, Shapiro R, Harmon W, Salvatierra O, Brennan D, McDiarmid S, Stock P, Pomfret L, Bennett W, Conti D, Metzger B, Sarwal M, Cosimi AB. Promotion of altruistic donation. Letter. Transplantation 2009; 88:847. Erratum in Transplantation 2009; 88:1145-1147.

53


32. Hanto DW. Book Review: When altruism isn’t enough: The case for compensating donors. Ed. Satel S. AEI Press, Washington DC. Am J Transplant 2009; 9:2855. Epub 2009 Oct 21.

33. Hanto DW, Ladin K. Is it always wrong to perform futile CPR? Letter. N Engl J Med 2010; 362:2034-2035.

34. Hanto DW, Veatch RM. Uncontrolled donation after circulatory determination of death (UDCDD) and determination of death. Editorial. Am J Transplant 2011;11:1351-1352. PMID: 21668641.

35. Ladin K, Hanto DW. Informed consent and living kidney donation: More (information) is not always better. Editorial. Am J Transplant 2011; 11:2547-2548. PMID: 22051183.

36. Robson SC, Hanto DW, Otterbein O, Ferran C. Fritz H. Bach M.D., (1934-2011). Xenotransplantation 2011; 18: ii-iii.

37. Ladin K, Hanto DW. Family physicians' role in discussing organ donation with patients and the public. Commentary. Virtual Mentor 2012; 14:194-200. PMID: 23352004

38. Hshieh TT, Sundaram V, Najarian R, Hanto DW, Karp SJ, Curry MP. Hepatitis B surface antigen as a marker for metastatic, recurrent hepatocellular carcinoma after liver transplant. Letter. Liver Transplant 2012;18:995-998 (DOI 10.1002/lt.23465).

39. Hanto DW. Perspective on Biliary Disease. In: Zinner MJ, Ashley SW, editors. Review. Maingot’s Abdominal Operations. 12th Edition. New York, NY. McGraw Hill: 2013. P. 1089-1091.

40. Wegiel B, Hanto DW, Otterbein LE. The social network of carbon monoxide in medicine. Review.Trends Mol Med 2013;19:3-11. Doi:10.1016/j.molmed.2012.10.001.Epub 2012 Nov 8. PMID:23140858

41. Ladin K, Hanto DW. Rationing lung transplants. Letter. N Engl J Med 2013; 369:2065-2066. PMID: 24256394

42. Chen C, Chapman WC, Hanto DW. Ischemia-reperfusion injury in kidney transplantation. Frontiers in Bioscience. Front Biosci (Ellite Ed). 2015 Jan 1;7:117-134. PMID 25553368.

43. Hanto DW, Klingensmith ME. Housestaff should also receive retirement benefits. Letter to the Editor RE: Are we paying our housestaff fairly? Ann Surg 2016; 263:e8-0. Epub 2014 Sept 10. PMID: 25211271.

44. O’Neill A, Hanto DW, Katzenstein HM. Cause and Effect: The Etiology of Pediatric Hepatocellular Carcinoma and the Role for Liver Transplantation. Editorial. Pediatr Transplant 2016; 20(7):878-879. PMID: 27726261

45. Ladin K, Hanto DW. Are geographic differences in transplantation inherently wrong? Curr Opin Organ Transplant 2017; 22:174-178. Epub 2017 Feb 15. PMID: 28151810.

46. Hanto DW. Current controversies in liver transplantation: Editorial Commentary. Curr Opin Organ Transplant 2017; 22:160-161. Epub 2017 Feb 15. PMID: 28212160

47. Hanto DW. Commentary on Chapter 117 Liver Transplantation. In: Fischer JE, Editor. Mastery of Surgery. 7th Edition. Philadelphia: Lippincott, Williams and Wilkins, 2017 (in press).

48. Ladin K, Zhang G, Hanto DW. Equitable access is not a secondary goal of organ allocation. Letter. Am J Transplant 2017; 17:3258. Epub 2017 Jul 4. PMID: 28597548

Book Chapters1. Hanto DW, Simmons RL. Association of cancer with renal transplantation. In: Rieselbach RE,

54


Ganick MB, editors. Cancer and the Kidney. Philadelphia: Lea and Febiger; 1982. p. 869-885.

2. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Purtilo DT, Simmons RL. Lymphoproliferative diseases in renal allograft recipients. In: Purtilo DT, editor. Immune Deficiency and Cancer. Epstein-Barr Virus and Lymphoproliferative Malignancies. New York: Plenum Press; 1984. p. 321-347.

3. Hanto DW, Simmons RL. Lymphoproliferative diseases in immunosuppressed patients. In: Morris PJ, Tilney N, editors. Progress in Transplantation. Edinburgh: Churchill Livingstone; 1984. p. 186-208.

4. Hanto DW, Simmons RL. Cancer in recipients of organ allografts. In: Williams GM, Burdick J, Solez K, editors. Kidney Transplant Rejection: Diagnosis and Treatment. New York: Marcel Dekker, Inc.; 1986. p. 697-725.

5. Berens ES, Shelton MW, Hanto DW. Current topics in renal transplantation. In: Gallagher TJ, Shoemaker WC, editors. Critical Care - State of the Art Volume 9. Fullerton, California: Society of Critical Care Medicine; 1988. p. 83-105.

6. Ascher NL, Hanto DW, Simmons RL. Immunobiology of allograft rejection. In: Flye MW, editor. Principles of Organ Transplantation. Philadelphia: W.B. Sanders Co.; 1989. p. 91-104.

7. Hanto DW. Clonality of post-transplant lymphoproliferative diseases (LPD). In: Penn I, Schmahl D, editors. DeNovo Cancers in Organ Transplant Patients. New York: Springer-Verlag; 1991. p. 33-45.

8. Hanto DW, Shelton MW, Simmons RL. Malignancies after organ transplantation. In: Paul LC, Solez K, editors. Organ Transplantation: Long-Term Results. New York: Marcel Dekker, Inc.; 1992. p. 319-352.

9. Hanto DW, Shelton MW, Simmons RL. Cancer in recipients of organ allografts. In: Williams GM, Burdick J, Solez K, editors. Kidney Transplant Rejection: Diagnosis and Treatment, Second Edition. New York: Marcel Dekker, Inc.; 1992. p. 697-725.

10. Hanto DW, Mohanakumar T. Transplantation immunobiology. In: Greenfield LJ, Mulholland MW, Oldham KT, Zelenock GB, editors. Surgery: Scientific Principles and Practice. Philadelphia: J.B. Lippincott; 1993. p. 461-500.

11. Hanto DW, Fischer JE. Liver and portal venous system: anatomy, function, and surgical diseases. In: Davis JH, Sheldon GF, editors. Surgery. A Problem-Solving Approach. Third Edition. St. Louis: Mosby; 1995. p. 1456-1513.

12. Hanto DW. Liver transplantation. In: Nyhus LM, Baker RJ, Fischer JE, editors. Mastery of Surgery. Third Edition. Boston: Little, Brown and Company; 1996, p. 1168-1183.

13. Hanto DW, Simmons RL. Cancer in recipients of organ allografts. In: Solez K, Burdick JF, and Williams GM, editors. Kidney Transplant Rejection: Diagnosis and Treatment. Third Edition. New York: Marcel Dekker, Inc.; 1997. p. 577-604.

14. Hanto DW, Whiting, JF, Valente JF. Transplantation of the liver and intestine. In: Norton JA, Bollinger RR, Chang AE, Lowry SF, Mulvihill SJ, Pass HI, and Thompson RW, editors. Surgery: Scientific Basis and Current Practice. New York: Springer-Verlag Inc.; 2000. p. 1473-1508.

15. Hanto DW. Liver transplantation. In: Baker RJ, Fischer JE, editors. Mastery of Surgery. Fourth Edition. Philadelphia: Lippincott, Williams and Wilkins; 2001. p. 1219-1234.

16. Hanto DW, Whiting JF, Valente JF. Transplantation of the liver and intestine. In: Norton JA, Bollinger RR, Chang AE, Lowry SF, Mulvihill SJ, Pass HI, and Thompson RW, editors. Essential Practice of Surgery. New York: Springer-Verlag Inc.; 2003. p. 623-636.

55


17. Hanto DW, Johnson SR. Liver transplantation. In: Fischer JE, editor. Mastery of Surgery. Fifth Edition. Philadelphia: Lippincott, Williams and Wilkins; 2007. p. 1196-1211.

18. Hanto DW, Johnson SR, Karp JS, Khwaja K. Liver transplantation. In: Norton JA, Barie PS, Bollinger RR, Chang AE, Lowry SF, Mulvihill SJ, Pass HI, Thompson RW, editors. Surgery: Basic Science and Clinical Evidence, 2nd Edition. New York: Springer-Verlag Inc.; 2008. p. 1787-1825.

19. Miksad R, Hanto D, Timmerman RD, Come S. Management of isolated liver metastases. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the Breast, Fourth Edition. Baltimore: Lippincott Williams & Wilkins; 2009. p. 1030-1037.

20. Hanto DW. Historical aspects of post-transplant lymphoproliferative disorders (PTLD). In: Dharnidharka V, Green M, Webber S, editors. Post-Transplant Lymphoproliferative Disorders. Heidelberg: Springer; 2009. p. 5-15.

21. Miksad R, Hanto D, Timmerman RD, Come S. Management of isolated liver metastases. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the Breast, Fifth Edition. Baltimore: Lippincott Williams & Wilkins; 2014, p. 1056-1066.

22. Ladin K, Wang R, Hanto DW. Chapter 143. National healthcare policy and the future of organ transplantation. In: Kirk AD, Knechtle SJ, Larsen CP, Madsen JP, Pearson TC, Webber SB, editors. Textbook of Organ Transplantation. Wiley-Blackwell, 2014. p. 1703-1723.

23. Hanto DW, Geevarghese SK, Baron C. Chapter 47. Portal Hypertension. In: Zinner MJ, Ashley SW, Hines OJ, editors. Maingot’s Abdominal Operations. McGraw-Hill, (2017, in press).

Proceedings of Meetings:

1. Witte MH, Hanto DW, Witte CL. Lymphatics in heart disease. In: Malek P, Barto V, Weubeder H, Witte MG, editors. Lymphology, Proceedings of the Sixth International Congress; 1977; Prague, Czechoslovakia. Prague: George Thieme Publishers, Stuttgart Avichenum, Czechoslovak Medical Press; 1979. p. 109-113.

2. Hanto DW, Simmons RL. Cancer after renal transplantation. In: Zurukzoglu W, Papadimitriou M, Pyrpasopoulos M, Sion Z, Zamboulis C, editors. Proceedings of the Eighth International Congress of Nephrology: Advances in Basic and Clinical Nephrology; Basel: S. Karger; 1981. p. 1199-1209.

3. Berens ES, Shelton MW, Vallera DA, Hanto DW. Characterization of a T-cell depleted mouse model which uses ricin anti-Thy 1.2 immunotoxin. Surgical Forum 1988; 39:363-364.

4. Shelton MW, Basler JT, Walp LA, Hanto DW. Both Ly-2+ and L3T4+ T-cells mediate skin allograft rejection in mice with severe combined immunodeficiency. Surgical Forum 1989; 15:381-383.

5. Truog RD, Lowney J, Hanto D, Caplan A, Brock D. Soliciting organs on the Internet. Med Ethics (Burlington, Mass) 2005; 12:5-8.

Professional Education Materials or Reports, in print or other media

1. Hanto DW, Strom T. Chiefs’ Corner: Introduction to Chief’s Corner. The Transplant Institute, Beth Israel Deaconess Medical Center. Transplant News July 2009;1(2):1.

2. Hanto DW, Strom T, Turka L. Chiefs’ Corner. How long will I wait? The Transplant Institute, Beth Israel Deaconess Medical Center. Transplant News March 2010;2(1):1.

56


3. Hanto DW, Strom T, Turka L. Chiefs' Corner. Dialysis access. The Transplant Institute, Beth Israel Deaconess Medical Center. Transplant News July 2011;3(1):1.

4. Hanto DW. Organ preservation. The SCORE (Surgical Council on Resident Education) Portal. http://www.surgicalcore.org/modulecontent.aspx?id=1000150. Published July 2015.

5. Helmink BA, Hanto DW. Transplant Immunology. The SCORE (Surgical Council on Resident Education) Portal. In press.

6. Grayson BL, Hanto DW. Post Transplant Malignancies. The SCORE (Surgical Council on Resident Education) Portal. In press.

Thesis:

Hanto DW. Mechanisms of cellular recruitment to rejecting allografts. Ph.D. Thesis. University of Minnesota, Department of Surgery, 1987.

Abstracts (only those containing data not yet published in complete form):

Published Abstracts

1. Hanto DW, Hoffman R, Simmons RL. Recognition of I-region determinants is necessary for recruitment of unsensitized lymphocytes to sites of allogeneic cellular interactions. Immunobiology 1982; 163:307.

2. Hanto DW, McCullough CS, Jendrisak MD, Brunt EM, Flye MW, Peters MG. Criteria for selection of patients with acute liver failure for orthotopic liver transplantation (OLT). Hepatology 1988; 8:1283.

3. Hadley GA, Phelan D, Flye MW, Hanto DW, Mohanakumar T. Lack of T-cell tolerance of noninherited maternal HLA antigens. Human Immunology 1989; I-42:81.

4. Hadley GA, Duff B, Hanto DW, Anderson CB, Mohanakumar T. Donor-specific transfusions down-regulate the generation of anti-donor cytotoxic T lymphocytes. Human Immunology 1989; I-42:100.

5. Brunt EM, Hanto DW. Accelerated acute rejection (AAR) in kidney allografts. Lab Invest 1990; 62:12A.

6. Phelan DL, Hibbett S, Wetter L, Mohanakumar T, Hanto DW. Recombinant erythropoietin: Effect on sensitization. Sixteenth Annual Meeting, American Society for Histocompatibility and Immunogenetics. Los Angeles California, November 3-7, 1990. Human Immunology abstracts publication 1990; p. 84.

7. Phelan DL, Duffy BF, Anderman C, Hanto DW, Anderson CB, Mohanakumar T. Donor specific blood transfusions in renal transplants: Influence of HLA-class II. Sixteenth Annual Meeting, American Society for Histocompatibility and Immunogenetics. Los Angeles, CA, November 3-7, 1990. Human Immunology abstracts publication 1990; p. 107.

8. Phelan DL, Jendrisak MD, Hanto DW, Mohanakumar T. Significance of B cell crossmatch on graft outcome. Sixteenth Annual Meeting, American Society for Histocompatibility and Immunogenetics. Los Angeles, CA, November 3-7, 1990. Human Immunology abstracts publication 1990; p.102.

9. White HM, Brunt EM, Regenstein F, Hanto DW, Marsh JW, Peters MG. Effect of alpha interferon and immune globulin therapy on hepatitis B viral infection in transplanted liver recipients. Hepatology 1990; 12:867.

57

http://www.surgicalcore.org/modulecontent.aspx?id=1000150


10. White H, Brunt E, Hanto DW, Marsh JW, Peters MG. Effects of alpha interferon therapy on the course of non-A, non-B hepatitis in transplanted solid organ recipients. Hepatology 1990; 12:1023.

11. Jain R, Hanto D, Sherman K, Martin S. Bile leaks after T-tube removal from liver transplant patients: Results of endoscopic management. Hepatology 1997; 24:528A.

12. Alexopoulos S, Hanto D, Strom T, Zheng X. Tolerance induction using IL-21 antagonizing fusion protein. Am J Transplant 2004; 4(Suppl. 8):186.

13. Kaufmann HM, Cheng Y, Cherikh WS, McBride MA, Hanto DW, Delmonico FL. Recipient history of cancer is independently associated with increased post-transplant de novo malignancies and decreased survival. Am J Transplant 2004; 4(Suppl. 8):205.

14. Alexopoulos S, Sanchez-Fueyo A, Hanto D, Zheng X, Strom TB. Regulatory T-cell proliferation and gene expression in response to alloantigen stimulation. Am J Transplant 2004; 4(Suppl. 8):263.

15. Paranjape C, Johnson SR, Hanto DW. Hepatic trisegmentectomy should be preceded by portal vein embolization to decrease the risk of post-operative liver failure. J Gastrointest Surg 2005; 9:556.

Other Abstract Presentations

1. Hanto DW. Malignancies associated with transplantation. Third Annual Scientific Session of International Society for Heart Transplantation. New Orleans, Louisiana, March 18-19, 1983.

2. Hanto DW. EBV related B-cell lymphoproliferative diseases in immunosuppressed patients. Eleventh Sapporo Cancer Seminar. Viruses, Immunodeficiency, and Human Cancer. Sapporo, Hokkaido, Japan, July 2-4, 1986.

3. Duffy B, Tyler JD, Anderson, CB, Hanto DW, Flye MW, Rodey G. Effect of donor-specific blood transfusion on in vitro alloreactive precursor cell frequencies. Eleventh International Congress of the Transplantation Society. Helsinki, Finland, August 3-8, 1986, abstract #P11.10.

4. Phelan D, Schutte L, Bollig B, Anderman C, Flye MW, Anderson CB, Hanto DW, Rodey G. B-cell antiglobulin crossmatch: A sensitivity test for detection of low-level class I HLA antibody. American Society for Histocompatibility and Immunogenetics. New Orleans, LA, September 14-18, 1986, abstract #208.

5. Anderson CB, Jendrisak MD, Sicard GA, Hanto DW, Flye MW. Twenty-three years of renal transplantation at Barnes Hospital. Missouri Chapter American College of Surgeons. Lake Ozark, MO, June 13-15, 1986.

6. Berens E, Shelton M, Vallera D, Hanto DW. Characterization of a T-cell depleted mouse model which uses ricin anti-Thy 1.2 immunotoxin. Federation of American Societies for Experimental Biology. Las Vegas, NV, May 1-5, 1988, abstract #1066.

7. Jendrisak MD, McCullough CS, Hanto DW, Flye MW. Cadaveric multiple organ donation experience at Washington University Medical Center: July, 1985 through May, 1988. Missouri Chapter American College of Surgeons. Lake Ozark, MO, June 10-12, 1988, abstract #32.

8. Mohanakumar T, Hadley GA, Kenyon N, Duffy B, Hanto DW, Anderson CB. Down-regulation of anti-donor CTL in recipients of donor-specific transfusions. First International Basic Sciences Symposium of the Transplantation Society. Chateau Lake Louise, Alberta, Canada, October 1-4, 1989, abstract #8.8-02.

9. So SKS, Cole B, Miller C, Schnaper HW, Vehasakari VM, Hanto DW. OKT3 for treatment of

58


moderate and severe, acute rejection in pediatric kidney transplantation. American Society of Transplant Physicians. Chicago, IL, May 29, 1990, abstract #67.

10. So SKS, Hanto DW, Miller C. Infection in the pediatric renal transplant recipients. Tenth Annual Meeting of the American Society of Transplant Physicians. Chicago, IL, May 28-29, 1991, abstract #P-2-60.

11. Peclet M, Pederson S, Dittrich V, Ryckman FC, Ballistreri, Hanto DW. Incidence of EBV seroconversion in pediatric liver transplant recipients. First International Congress on Pediatric Transplantation. Minneapolis, MN, August 29-September 1, 1993, abstract #10.

12. Rossi S, Schroeder T, Peclet M, Schlueter K, Torpy J, Hanto D. Intraoperative administration of OKT-3 in liver transplant recipients (LTR): Associated cytokine release and hemodynamic parameters. Society of Critical Care Medicine. Orlando, FL, January 30-February 3, 1994, abstract #93.

13. Rossi SJ, Schroeder TJ, Schleuter KT, Hanto DW. Pharmacokinetics (PK) of OKT-3 in liver transplant patients (LTP) during induction immunosuppression. Society of Clinical Pharmacology and Therapeutics. New Orleans, LA, March 30, 1994, abstract #104.

14. Rossi SJ, Ferguson MA, Goretsky S, Gelhot AR, Schroeder TJ, Hanto DW. A randomized prospective trial of fluconazole vs. nystatin/clotrimazole for fungal prophylaxis in liver transplant recipients. 14th Annual Meeting of the American Society of Transplant Physicians, Chicago, IL, May 14-17, 1995, abstract #P-96.

15. Valente JF, Rahim A, Vu D, Alspaugh J, Goretsky S, Weber F, Hanto DW. Percutaneous transhepatic thrombolysis (PTHT) for portal venous system thromboses following orthotopic liver transplantation. Joint Congress on Liver Transplantation, London, UK, September 27-20, 1995, abstract #P239.

16. Jain R, Hanto DW, Sherman K, Martin SP. Bile leaks after T-tube removal from liver transplant patients: Results of endoscopic management. Midwest Gut Club, Cincinnati, OH, March 2, 1996.

17. Uchiyama K, Rossi S, Ferguson M, Ruger JK, Walp LA, Hanto DW. The administration of an anti-αβ T cell receptor monoclonal antibody in mice leads to T cell-depletion, inhibition of alloresponses, and anergy. 15th Annual Meeting of the American Society of Transplant Physicians, Dallas, TX, May 26-29, 1996, abstract #P156.

18. Martin J, Fleck P, Schroeder J, Whiting J, Hanto D. The cost of rejection in liver allograft recipient. 16th Annual Meeting of the American Society of Transplant Physicians, Chicago, IL, May 10-14, 1997, abstract #218.

19. Martin JE, Schroeder T, Hanto DW, Bey C. Pharmacokinetics of the interaction between itraconazole oral solution and cyclosporine in stable post-liver transplant recipients. American Society Health System Pharmacists Midyear Clinical Meeting, December 1998, abstract #33.

20. Zavala EY, Kappa J, Whiting J, Hanto DW. Transplant quality monitoring. UNOS Transplant Management Forum, San Diego, CA, April 11-13, 1999.

21. Johnson SR, Koehler A, Pennington LJ, Hanto DW. Long-term results of surgical repair of bile duct injuries following laparoscopic cholecystectomy. Central Surgical Association, 57 th Annual Meeting, Chicago, IL, March 2-4, 2000.

22. Phillips A, Walker EL, Martin, J, First MR, Hanto DW, Whiting JF. Quality of life (QOL) as a predictor of morbidity, mortality and resource utilization after solid organ transplant. XVIII International Congress of the Transplantation Society, Rome, Italy, August 27-September 1, 2000, abstract #0706.

59


23. Johnson SR, Kelly BS, Pennington LJ, Hanto DW. A single center experience with extrahepatic cholangiocarcinomas. Central Surgical Association, 58 th Annual Meeting, Tucson, AZ, March 7-10, 2001.

24. Zavala EY, Rolfes K, Dougherty E, Pirro L, Aranda-Michel J, Hanto DW. Adult–to-adult living liver donation hospital resource utilization and reimbursement economics: Our initial experience. Transplant 2001, Chicago, IL, May 11-16, 2001, abstract #298.

25. Hanto DW, Whiting JF, Johnson SR, Alonso MH, Vu DN, Alspaugh JP, Buell JF, Hanaway MJ. Important surgical lessons learned from adult right lobe living related liver transplants. Minimizing surgical complications. Transplant 2001, Chicago, IL, May 11-16, 2001, abstract #286.

26. Large AR, Martin JE, Aranda-Michel J, Hanto DW, Whiting JF. Incidence of bone complications and associated resource utilization in liver transplant patients. Transplant 2001, Chicago, IL, May 11-16, 2001, abstract #723.

27. Mueller EW, Martin JE, Rolfes KS, Auble PM, Aranda-Michel J, Weber FL, Hanto DW.Clinical and economic impact of late steroid withdrawal in a stable liver transplant population. Transplant 2001, Chicago, IL, May 11-16, 2001, abstract #722.

28. Buell JF, Aull MJ, Munda R, Alexander JW, Fidler J, Rilo H, Hanto D, Lo A, Hanaway M, Lewis D, First MR, Woodle ES. A donor selection algorithm for non-heart-beating donors allows high retrieval rates and excellent graft survival. Transplant 2001, Chicago, IL, May 11-16, 2001, abstract #674.

29. Hanto DW, Whiting JF, Johnson SR, Alonso MH, Vu DN, Alspaugh JP, Buell JF, Hanaway MJ. Minimizing surgical complications after adult right lobe (RL) living related liver transplants (ALDRLT). ILTS ELTA LICAGE Berlin 2001, Berlin, Germany, July 11-13, 2001.

30. Aull MJ, Kelly B, Zavala E, Johnson S, Rolfes K, Weber F, Hanaway M, Martin JE, Reisner CM, Buell JF, Hanto DW. Morbid obesity: A contraindication to liver transplantation. ILTS ELTA LICAGE Berlin 2001, Berlin, Germany, July 11-13, 2001.

31. Dewan D, Choe KA, Moulton JS, Hanto DW. Review of the abdominal complications of adult cadaveric and living related donor liver transplantation. 87th Scientific Assembly and Annual Meeting of Radiological Society of North America, Chicago, IL, November 25-30, 2001.

32. Gavigan KM, Martin JE, Large AR, Rolfes K, Auble P, Bass M, Trumbull L, Zavala EY, Weber F, Hanaway MJ, Hanto DW, Woodle ES, Buell JF, Aranda-Michel J. Aggressive pre-transplant intervention results in decreased bone complications in adult liver transplant recipients. American Transplant Congress, Transplant 2002, Washington, DC, April 26-May 1, 2002, abstract #13.

33. Zavala EY, Martin JE, Trumbull LA, Benjey J, Aranda-Michel J, Hanto DW. Adult living donor liver transplantation (LDLT): Cost comparison to adult cadaver donor liver transplantation (CDLT). American Transplant Congress, Transplant 2002, Washington, DC, April 26-May 1, 2002, abstract #389.

34. Punch J, Bohnangel A, Brown K, Elkhammas E, McChesney L, Merion R, Rouch D, Seaman D, Vogt D, Hanto, D. MELD is positively correlated with mortality in status 2A patients from region 10. American Transplant Congress, Transplant 2002, Washington, DC, April 26-May 1, 2002, abstract #640.

35. Worley K, Weber F, Hanaway MJ, Aranda-Michel J, Sherman K, Kelly B, Martin J, Auble P, Bass M, Zucker S, Zavala E, Hanto DW, Woodle ES, Buell JF. Successful use of short-term anti-HBs therapy to increase the use of hepatitis B core antibody positive liver allografts. American Transplant Congress, Transplant 2002, Washington, DC, April 26-May 1, 2002,

60


abstract #1157.

36. Buell JF, Weber F, Hanaway MJ, Aranda-Michel J, Sherman K, Kelly B, Martin J, Bass M, Zucker S, Zavala EY, Hanto DW, Worley K, Woodle ES. Safe and efficacious use of hepatitis B core antibody positive liver allografts utilizing short-term anti HBs therapy. Eighth Annual Congress of the International Liver Transplantation Society. Chicago, IL, June 13-15, 2002, abstract #143.

37. Machen A, Martin JE, Solomkin J, Hanaway MJ, Aranda-Michel J, Weber F, Sherman K, Bass M, Auble P, Trumbull L, Hanto DW, Woodle ES, Buell JF. Consequences of vancomycin-resistant enterococcus (VRE) in liver transplant: a matched controlled study. Eighth Annual Congress of the International Liver Transplantation Society. Chicago, IL, June 13-15, 2002, abstract #169.

38. Gavigan KM, Martin JE, Large AR, Rolfes K, Auble P, Bass M, Trumbull L, Zavala EY, Weber F, Hanaway MJ, Hanto DW, Woodle ES, Buell JF, Aranda-Michel J. Aggressive pre-transplant intervention results in decreased bone complications in adult liver transplant recipients. Eighth Annual Congress of the International Liver Transplantation Society. Chicago, IL, June 13-15, 2002, abstract #255.

39. Yadlapalli N, Cherikh WS, Kauffman M, Pavlakis M, Hanto D. Colon cancer in solid organ recipients. American Society of Transplant Surgeons Third Winter Symposium. Miami Beach, FL, January 24-26, 2003, abstract #31.

40. Doty TC, Merchen T, Gupta M, Hanaway M, Ahmad S, Lowy A, Matthews J, Pennington L, Hanto DW, Woodle ES, Buell JF, The University of Cincinnati, Cincinnati, OH. Comparison of laparoscopic and open surgical management of hepatic cysts. American Hepato-Pancreato-Biliary Association (AHPBA) Fourth Meeting. Miami Beach, FL, February 27-March 2, 2003, abstract #P55.

41. Kim J, Ahmad SA, Lowy AM, Matthews JB, James LE, Hanto DW. Biliary fistulas following hepatic resection: risk factors and treatment strategies. Society for Surgery of the Alimentary Tract 44th Annual Meeting. Orlando, FL, May 18-21, 2003.

42. Martin J, Craycraft M, Hanaway M, Hanto D, Buell J, Rudich S. Induction immunosuppression in liver transplant recipients: a 14 year, single center review. International Liver Transplantation Society 9th Congress. Barcelona, Spain, June 18-21, 2003, abstract #168.

43. Cherikh WS, Hanto DW, Kauffman HM, Swinnen LJ. Impact of induction and maintenance immunosuppression on postransplant lymphoproliferative disorder in primary kidney transplant recipients with Epstein-Barr virus negative or positive serostatus. American Society of Transplant Surgeons State of the Art Winter Symposium 2005. Miami Beach, FL, January 21-23.

44. Cherikh WS, Kauffman HM, Hanto DW, Swinnen LJ. Association of immunosuppression and postransplant lymphoproliferative disorder (PTLD) in primary kidney transplant recipients with Epstein-Barr virus (EBV) negative and positive serostatus. American Transplant Congress 2005. Seattle, WA, May 21-25, abstract #390.

45. Cherikh WS, Kauffman HM, Shames BD, Cheng Y, Hanto DW. Association of different immunosuppressive regimens with posttransplant de novo malignancies in liver recipients. American Transplant Congress 2005. Seattle, WA, May 21-25, abstract #930.

46. Khwaja K, Johnson S, Zaheer A, Pavlakis M, Karp S, Monaco A, Bratton C, Hanto D. Donor kidney volume/recipient weight ratio affects renal function after living donor kidney transplantation. American Transplant Congress 2005. Seattle, WA, May 21-25, abstract #1263.

47. Blumberg E, Olthoff K, Roland M, Ragni M, Hanto D, Sherman K, Lu A, Dove L, Light J, Redfield R, Stock P. Expanded criteria donors can be used successfully for transplantation of

61


HIV infected individuals. American Transplant Congress 2005. Seattle, WA, May 21-25, abstract #1294.

48. Wong M, D’Agata E, Curry M, Johnson SR, Nagy S, Khwaja K, Karp S, Hanto D. Evolution of antimicrobial resistance in bacteria and yeast in a newly established liver transplant program. American Transplant Congress 2005. Seattle, WA, May 21-25, abstract #1383.

49. Rogers CC, Johnson S, Snow E, Hanto DW, Khwaja K, Karp S, Egbuna O, Mandelbrot D, Pavlakis M, Curry M. Early sirolimus conversion is superior to late sirolimus conversion in reversing renal dysfunction in liver transplant recipients. Oral presentation. World Transplant Congress 2006. Boston, MA, July 22-27, abstract #493.

50. Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW. Deceased donors with primary CNS malignancies: an underused organ source. World Transplant Congress 2006. Boston, MA, July 22-27, abstract #780.

51. Khwaja K, Johnson S, Pavlakis M, Karp S, Rogers C, Mandelbrot D, Monaco A, Hanto D. Prednisone-free immunosuppression in kidney transplant recipients from donors after cardiac death (DCD). World Transplant Congress 2006. Boston, MA, July 22-27, abstract #1307.

52. Egbuna O, Johnson S, Pavlakis M, Khwaja K, Karp S, Rogers C, Curry M, Snow E, Hanto D, Mandelbrot D. Efficacy and safety of conversion from calcineurin inhibitors to sirolimus after early steroid withdrawal kidney transplantation. World Transplant Congress 2006. Boston, MA, July 22-27, abstract #1329.

53. Johnson SR, Curry M, Alexopoulos S, Karp SJ, Khwaja K, Hanto DW. Local variation in the occurrence of primary nonfunction in adult liver transplantation. World Transplant Congress 2006. Boston, MA, July 22-27, abstract #1416.

54. Bleibel W, Johnson SR, Ghosh T, Mainali B, Khwaja K, Karp SJ, Hanto DW, Curry MP. Computed tomography liver volumetrics of the liver predicts outcome in patients with endstage liver disease. World Transplant Congress 2006. Boston, MA, July 22-27, abstract #1417.

55. Ferrada PA, Brennan D, Curry MP, Nasser I, Johnson SR, Khwaja K, Karp S, Goldberg SN, Hanto DW. Radiofrequency ablation of hepatocellular carcinoma is safe and effective in controlling tumor growth in wait listed liver transplant candidates. World Transplant Congress 2006. Boston, MA, July 22-27, abstract #2784.

56. Rogers CC, Johnson S, Snow E, Hanto DW, Khwaja K, Karp S, Egbuna O, Mandelbrot D, Pavlakis M and Curry M. Early sirolimus conversion is superior to late sirolimus conversion in reversing renal dysfunction in liver transplant recipients. American College of Clinical Pharmacy 2006 Annual Meeting. St. Louis, MO, October 26-29, abstract #278.

57. Ho KJ, Owens CD, Johnson S, Khwaja K, Pavlakis M, Mandelbrot D, Saidi RF, Kop D, Malek S, Tullius S, Whiting J, Hanto DW, Karp SJ. Sustained donor hypotension and long times to death during DCD kidney procurement correlate with increased rates of DGF and worse long term renal function. American Society of Transplant Surgeons State of the Art Winter Symposium 2007. Marco Island, FL, January 12-14.

58. Rogers C, Bain B, Johnson S, Wong M, Stablein D, Stock P, Frasetto L, Hanto D, Roland M. Renal sparing effects of rapamycin in HIV+ transplant recipients. American Transplant Congress 2007. San Francisco, CA, May 5-9, abstract #57.

59. Rogers C, Johnson S, Gibbons M, Khwaja K, Karp S, Egbuna O, Mandelbrot D, Pavlakis M, Hanto D, Curry M. Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients. American Transplant Congress 2007. San Francisco, CA, May 5-9, abstract #632.

60. Yoon M, Konduru B, Gallo DJ, Otterbein LE, Hanto DW. Carbon monoxide prevents rejection

62


and delayed graft function following kidney transplantation in rats and pigs. American Transplant Congress 2007. San Francisco, CA, May 5-9, abstract #1049.

61. Blumberg E, Barin B, Olthoff K, Stock P, Hanto D, Murphy B, Simon D, Light J, Range M, Roland M. Bacterial infections in HIV positive transplant recipients. American Transplant Congress 2008. Toronto, ON, May 31-June 4, abstract #17.

62. Rodrigue JR, Lisson GL, Nelson DR, Reed AI, Curry M, Hanto DW. MELD and prediction of quality of life one year after liver transplantation. American Transplant Congress 2008. Toronto, ON, May 31-June 4, abstract #156.

63. Cherikh WS, Hanto DW, Kirk AD. The effect of sirolimus on de novo cancer after kidney transplantation: an OPTN database analysis. American Transplant Congress 2008. Toronto, ON, May 31-June 4, abstract #294.

64. Rodrigue JR, Anton Ellis T, Nelson DR, Reed AI, Hanto DW, Curry M. A cross-sectional study of fatigue before and after liver transplantation. American Transplant Congress 2008. Toronto, ON, May 31-June 4, abstract #584.

65. Francis J, Palmer M, Curry M, Patel P, Pavlakis M, Johnson S, Karp S, Khwaja K, Donohoe K, Hanto D, Mandelbrot D. Evaluation of native kidney (NK) recovery after simultaneous liver-kidney transplant (SLK). American Transplant Congress 2008. Toronto, ON, May 31-June 4, abstract #586.

66. Rodrigue JR, Antonellis T, Hanto DW, Curry M. Patients’ willingness to accept liver transplantation from expanded criteria donors. American Transplant Congress 2008. Toronto, ON, May 31-June 4, abstract #1353.

67. Rogers CC, Horwedel T, Asipenko N, Pavlakis M, Egbuna O, Johnson S, Karp S, Khwaja K, Chudzinski R, Hanto DW, Mandelbrot D. Efficacy of low dose thymoglobulin induction for renal transplantation in the setting of early steroid withdrawal. American Transplant Congress 2008. Toronto, ON, May 31-June 4, abstract #1561.

68. Croome KP, Chudzinski R, Hanto DW. Increasing time delay from presentation until referral to tertiary care surgeons for hepatobiliary (HPB) malignancies. University of Western Ontario Research Day. London, ON, April 29, 2009.

69. Stock P, Roland M, Hanto D, Johnson S, Pavlakis M, Light J, Barin B, Jayaweera D, Murphy B. Early and unexpected results in a multicenter study of kidney transplantation in HIV-infected recipients. American Transplant Congress 2009. Boston, MA, May 30-June 4, abstract #23.

70. Dib MJ, Kennealey PT, Farrell ML, Mandelbrot D, Curry M, Hertl M, Ko DSC, Cosimi AB, Tsoulfas G, Saidi R, Elias N, Johnson SR, Hanto DW, Markmann JF, Karp SJ. Risk factors for chronic kidney disease (CDK) after liver transplantation: implications for performing combined liver and kidney transplantation (CLKT). American Transplant Congress 2009. Boston, MA, May 30-June 4, abstract #247.

71. Mandelbrot D, Pavlakis M, Johnson S, Karp S, Hanto D, Rodrigue J. Practices and barriers in living kidney donor follow-up: a survey of U.S. transplant centers. American Transplant Congress 2009. Boston, MA, May 30-June 4, abstract #416.

72. Dib MJ, Ferrada P, Challies T, Nasser I, Brennan DD, Goldberg SH, Chudzinski R, Karp SJ, Johnson SR, Hanto DW, Curry MP. Tumor burden as determined by radiological volumetry is an accurate predictor of recurrence after liver transplantation for HCC utilizing RFA as a bridging therapy. American Transplant Congress 2009. Boston, MA, May 30-June 4, abstract #888.

73. Kuramitsu K, Wegiel B, Csizmadia E, Otterbein LE, Hanto DW. Exposure to carbon monoxide enhances liver regeneration in mice. American Transplant Congress 2009. Boston, MA, May 30-June 4, abstract #896.

63


74. Rogers C, Bain B, Johnson S, Wong M, Stablein D, Stock P, Frasetto L, Hanto D, Roland M. Rapamycin fails to yield a renal sparing effect in HIV+ transplant recipients. American Transplant Congress 2009. Boston, MA, May 30-June 4, abstract #1082.

75. Chudzinski R, Khwaja K, Teune P, Tang H, Pavlakis M, Rogers C, Johnson S, Karp S, Hanto D, Mandelbrot D. Successful DCD kidney transplantation using early corticosteroid withdrawal. American Transplant Congress 2009. Boston, MA, May 30-June 4, abstract #1336.

76. Hanto DW, Maki T, Thomas M, Wegiel B, Gallo D, Bersenbrugge A, Cooreman M, Szabo C, Otterbein LE. Carbon monoxide reduces delayed graft function of a kidney allograft in swine by reducing cell death and inflammation and by enhancing repair. American Transplant Congress 2009. Boston, MA, May 30-June 4, abstract #1391.

77. Abdul Q, Chudzinski R, Tang H, Mandelbrot D, Wong M, Karp S, Johnson S, Hanto D, Pavlakis M. Infection incidence in pancreas after kidney transplantation compared to simultaneous kidney pancreas transplantation. American Transplant Congress 2009. Boston, MA, May 30-June 4, 2009, abstract #1891.

78. Croome KP, Chudzinski R, Hanto DW. Increasing time delay from presentation until referral to tertiary care surgeons for hepatobiliary (HPB) malignancies. Canadian Surgery Forum. Victoria, BC, September 11, 2009 (poster presentation).

79. Kuramitsu K, Wegiel B, Csizmadia E, Otterbein LE, Hanto DW. The effect of carbon monoxide on liver regeneration after hepatectomy. American Association for the Study of Liver Diseases. The Liver Meeting 2009. Boston, MA, October 30-November 3, 2009, abstract #713.

80. Kuramitsu K, Csizmadia E, Otterbein LE, Hanto DW. A new strategy to accelerate liver regeneration after hepatectomy. American Society of Transplant Surgeons Annual State of the Art Winter Symposium. Fort Lauderdale, FL, Jan 2010, abstract #13 (oral poster presentation).

81. Kuramitsu K, Otterbein LE, Csizmadia E, Hanto DW. Inhaled carbon monoxide enhances liver regeneration after hepatectomy mediated by hepatocyte growth factor and cmet. American Transplant Congress 2010, Plenary Session III. San Diego, CA, May 4, 2010, abstract #341.

82. Kuramitsu K, Csizmadia E, Otterbein LE, Hanto DW. Inhaled carbon monoxide enhances liver regeneration alter hepatectomy. Rising Star Symposium, International Liver Transplantation Society 16th Annual International Congress. Hong Kong, China, June 17, 2010, abstract O-14.

83. Ladin K, Chretien Y, Rodrigue JR, Mandelbrot D, Pavlakis M, Langnas E, Lopez J, Hanto DW. Racial disparities in living donor rates: What predicts the likelihood of receiving a donor? The Transplantation Society XXIII International Congress. Vancouver, BC, August 15-19, 2010, abstract #502 (oral poster presentation M0020.01).

84. Ladin K, Chretien Y, Langnas E, Rodrigue JR, Pavlakis M, Mandelbrot D, Hanto DW. What are my chances? Age-based disparities in living donor kidney transplantation. The Transplantation Society XXIII International Congress. Vancouver, BC, August 15-19, 2010, abstract #2636 (oral presentation 015.03).

85. Ladin K, Langnas E, Rodrigue JR, Pavlakis M, Mandelbrot D, Hanto DW. Disparities in living donor kidney transplantation – the potential role of social networks. The Transplantation Society XXIII International Congress. Vancouver, BC, August 15-19, 2010, abstract #2685 (oral presentation 015.01).

86. Kuramitsu K, Popov Y, Csizmadia E, Sharma A, Sverdlov D, Schuppan D, Hanto DW, Otterbein LE. Carbon monoxide promotes liver regeneration after hepatectomy in fibrotic mice. 61st Annual Meeting of the American Association for the Study of Liver Diseases. Boston, MA, October 29-November 2, 2010, abstract #252 (oral presentation).

87. Nandy N, Rogers C, Nasser I, Challies TL, Karp S, Johnson S, Hanto DW, Curry MP. Impact of

64


sirolimus based immunosuppression on fibrosis progression in HCV liver transplant recipients. 61st Annual Meeting of the American Association for the Study of Liver Diseases. Boston, MA, October 29-November 2, 2010, abstract #151 (oral presentation).

88. Miksad RA, Lai KC, Barski T, Babalola A, Hanto DW, Faintuch S, Ahmed M, Mendiratta-Lala M, Lake-Bakaar G. Consistency of actual management with multidisciplinary liver tumor conference consensus conference. 61st Annual Meeting of the American Association for the Study of Liver Diseases. Boston, MA, October 29-November 2, 2010, abstract 1958 (oral presentation).

89. Ladin K, Chretien Y, Langnas E, Lopez J, Rodrigue JR, Pavlakis M, Mandelbrot D, Hanto DW. Racial disparities in living donor rates: what predicts the likelihood of receiving a donor? American Public Health Association Conference (APHA). Denver, CO, November 6-10, 2010 (oral presentation). Student Presentation Award from the Medical Care Section of the APHA.

90. Ladin K, Chretien Y, Langnas E, Lopez J, Rodrigue JR, Pavlakis M, Mandelbrot D, Hanto DW. What are my chances? Age-based disparities in living donor kidney transplantation. American Public Health Association Conference (APHA). Denver, CO, November 6-10, 2010 (poster presentation).

91. Kuramitsu K, Sverdlov D, Csizmadia E, Burkly LC, Schuppan D, Hanto DW, Otterbein LE, Popov Y. Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation. 62nd Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, November 8, 2011, abstract #1811 (poster presentation). Presidential Poster of Distinction.

92. Harbell J, Nissen N, Olthoff K, Florman SS, Hanto DW, Light J, Bartlett ST, Tzakis AG, Pearson TC, Barin B, Fung J, Stock PG. Surgical complications in 275 human immunodeficiency virus (HIV) infected liver and/or kidney transplant recipients. 7 th Annual Academic Surgical Congress. Las Vegas, NV, February 14-16, 2012.

93. Ladin K, Langnas E, McKellar R, Rodrigue JR, Christakis NA, Hanto DW. Implications of social networks: how who you know could save your life (and give you a kidney). American Transplant Congress. Poster Session: Non-Organ Specific: Disparities to Outcome and Access. Boston, MA, June 2, 2012, poster #720 (oral presentation).

94. Rogers C, Bradley S, Hanto D, Evenson A. Impact of early versus late conversion from a calcineurin inhibitor to sirolimus on the incidence of wound complications in liver transplant recipients. American Transplant Congress. Poster Session: Outcomes of Liver Transplantation. Boston, MA, June 2, 2012, poster #775 (oral presentation).

95. Rodrigue JR, Nelson DR, Reed AI, Hanto DW, Paek MJ, Senat S, Curry MP. Prevalence and predictors of inmunosuppression nonadherence following liver transplantation. 24 th International Congress of the Transplantation Society. Berlin, Germany, July 17, 2012, abstract A-453-0007-00495 (oral presentation).

96. Rodrigue JR, Hanto DW, Ghaziani T, Curry MP. Predictors of relapse to any alcohol use after liver transplantation: utility of the alcohol relapse risk assessment. 24 th International Congress of the Transplantation Society. Berlin, Germany, July 17, 2012, abstract A-453-0007-00334 (oral presentation).

97. Ladin K, Wang R, Hanto DW, Rodrigue JR. Do social capital and racial composition predict organ donation? 24th International Congress of the Transplantation Society. Berlin, Germany, July 17, 2012, abstract 2530 (oral presentation).

98. Ladin K, Langnas E, Christakis NA, Rodrigue JR, Ayanian JZ, Hanto DW. Implications of social networks: how who you know could save your life (and give you a kidney). 24 th

International Congress of the Transplantation Society. Berlin, Germany, July 19, 2012, poster PO35.063 (oral presentation).

65


99. Milas E, Feurer I, Truscott C, Gray J, Wilson N, Bala S, Dreher T, Wigger M, Shah A, Lambright E, Hanto D. Comparison of Actual Versus Goal Tacrolimus Levels Post Cardiothoracic Transplant. American Transplant Congress. Poster Session: Hearts and VADs in Depth – The Force Awakens. Boston, MA, June 12, 2016, poster #B165.

100. Patel R, Feurer I, Karp S, Gillis L, Katzenstein H, Lovvorn III H, Pietsch J, Chung D, Tiao G, Hanto D. Long-Term Outcomes After Pediatric Liver Transplantation for Malignant Liver Tumors: Effects of Era and Age. American Transplant Congress. Oral Abstract Session: Pediatric Liver Transplant. Boston, MA, June 13, 2016, publication #355 (oral presentation).

101. Ladin K, Gordon E, Butt Z, Lavelle T, Daniels N, Hanto D. Perceived legitimacy of using social support for transplant eligibility: results from a national survey of transplant clinicians. American Transplant Congress. Philadelphia, PA, April 29-May 3, 2017 (accepted for poster presentation).

102. Ladin K, Emerson J, Butt Z, Gordon E, Hanto D, Lavelle T. The impact of social support on kidney transplant listing decisions: results from a discrete choice experiment. American Transplant Congress. Philadelphia, PA, April 29-May 3, 2017 (accepted for podium presentation).

103. Ladin K, Emerson J, Butt Z, Gordon E, Hanto D, Lavelle T. The impact of social support on kidney transplant listing decisions:results from a discrete choice experiment. AcademyHealth 2017 Annual Research Meeting. New Orleans, LA, June 25-27 (accepted for poster presentation).

104. Ladin, K, Emerson J, Butt Z, Gordon EJ, Hanto D, Daniels N, Lavelle TA. Ethical Ideology Predicts Use of Social Support in Kidney Transplant Listing Decisions: Results from a Discrete Choice Experiment. AcademyHealth 2017 Interest Group Meeting. Surgical and Perioperative Care Top Abstracts of 2017. New Orleans, LA, June 24 (accepted for presentation).

105. Ladin K, Gordon E, Butt Z, Lavelle T, Daniels N, Hanto D. Using Social Support to Determine Transplant Eligibility: Results from a National Survey of Transplant Clinicians. AcademyHealth 2017 Annual Research Meeting, New Orleans, LA, June 25-27 (accepted for poster session).

66

Documents

CURRICULUM VITAE AND BIBLIOGRAPHY › uploads › 4 › 1 › 5 › 1 › 41… · Web viewABO incompatible liver transplantation with no immunological graft losses utilizing total